Short answer: Yes. Allergies do not directly cause bacterial sinus infections — but they create the exact conditions that make sinus infections inevitable. Allergic inflammation swells the nasal and sinus mucosa, narrows the drainage pathways, impairs mucociliary clearance, and creates a stagnant, inflamed environment where bacteria establish themselves and thrive. The prevalence of allergic rhinitis in patients with chronic rhinosinusitis ranges from 40 to 84 percent — making it the single most common comorbid condition in sinus disease. At the Sinus and Allergy Wellness Center of North Scottsdale, allergy is one of the first things we evaluate in every patient with recurrent sinus infections — because treating the sinus without treating the allergy that drives it produces only temporary relief.

How Allergies Set Up Sinus Infections

To understand the connection, you have to understand what allergic inflammation actually does to the sinuses. When an allergic patient is exposed to a triggering allergen — pollen, dust mite, mold spore, pet dander — the immune system mounts a type 2 inflammatory response driven by IgE antibodies bound to mast cells in the nasal mucosa. Those mast cells degranulate, releasing histamine, leukotrienes, and a cascade of other inflammatory mediators. The result is mucosal swelling, increased mucus production, and ciliary dysfunction — all happening simultaneously.

Each of these consequences directly compromises sinus health. The mucosal swelling narrows the ostiomeatal complex — the critical drainage junction where the maxillary, anterior ethmoid, and frontal sinuses all drain. When that junction swells, mucus cannot drain. Stagnant mucus inside the sinus creates an anaerobic, warm, nutrient-rich environment that is ideal for bacterial colonization. The ciliary dysfunction compounds this — the hair-like cilia that normally move mucus out of the sinuses are slowed or paralyzed by inflammatory mediators, further impairing clearance. Bacteria establish themselves in this environment, and a sinus infection follows.

This is not a theoretical relationship. The AAO-HNS 2025 Adult Sinusitis Update identifies allergic rhinitis as a premorbid factor in newly diagnosed chronic rhinosinusitis, noting that patients with both allergic rhinitis and CRS are more symptomatic than nonallergic CRS patients with similar CT findings. A large CRS cohort study found that allergic rhinitis was independently associated with frequent acute exacerbations of CRS, with an adjusted odds ratio of 1.96 — meaning allergic patients were nearly twice as likely to experience recurrent acute flares on top of their chronic disease.

The Arizona Allergy Burden — Why This Matters Especially Here

For patients in Scottsdale, Phoenix, and the greater Maricopa County area, the allergy-sinus connection is amplified by one of the most aggressive allergen environments in the country. The Sonoran Desert has a unique and extensive allergen profile that surprises many patients who moved to Arizona expecting relief from their allergies.

Desert broom — a ubiquitous Scottsdale and Phoenix landscape plant — produces enormous quantities of pollen from late summer through fall, often extending the allergy season well into November. Olive trees, widely planted throughout the Phoenix metro area in earlier decades before their pollen became a recognized problem, produce highly allergenic pollen in spring. Mulberry, Bermuda grass, and desert dust mites — which thrive in the low-humidity desert environment differently than their humid-climate counterparts — contribute to a year-round allergen burden that keeps many patients in a state of near-constant allergic stimulation.

This sustained allergen exposure means that for patients in North Scottsdale, Paradise Valley, Fountain Hills, Cave Creek, and surrounding areas, the nasal and sinus mucosa may never have a chance to fully recover between exposures. Chronic low-grade allergic inflammation becomes the baseline — and the threshold for a bacterial sinus infection to establish itself drops accordingly.

Allergy and Sinusitis Are Not the Same — and Treating One as the Other Fails Both

One of the most common diagnostic errors we encounter at SAWC is a patient who has been treated for recurrent sinus infections with antibiotics when the primary driver is allergy. Antibiotics treat bacteria. They do not reduce IgE-mediated inflammation, reduce mucosal swelling, or improve sinus drainage in an allergically inflamed nose. A patient whose sinus infections are driven primarily by undertreated allergic rhinitis will continue to cycle through infections regardless of which antibiotic is prescribed, because the environment creating the infections has not been addressed.

The reverse error is equally common — a patient whose sinus symptoms are attributed entirely to allergy, managed with antihistamines and nasal steroid spray, while actual chronic sinusitis with objective mucosal changes goes undiagnosed and untreated. The AAO-HNS 2025 guideline is explicit: symptoms alone cannot confirm the diagnosis of CRS. Objective evidence — nasal endoscopy, CT imaging — is required. Treating presumed allergy without ruling out underlying sinusitis delays appropriate intervention.

Central Compartment Atopic Disease — A Specific Allergy-Driven Sinus Subtype

An increasingly recognized subtype of sinus disease directly driven by allergy is central compartment atopic disease — CCAD. In CCAD, allergic inflammation concentrates specifically in the middle turbinate and central nasal compartment, producing a distinctive pattern of edema and thickening that can progress to involve the central sinus cavities. A prospective study found that 14 of 15 CCAD patients were sensitive to at least one allergen both locally and systemically — and some had local allergen sensitivities that were not detected by standard systemic allergy testing. For patients whose sinus disease appears predominantly central on endoscopy and CT, allergy — including local allergic rhinitis missed by standard testing — deserves specific evaluation.

What a Complete Evaluation Looks Like When Both Are Present

When a patient presents with recurrent sinus infections and a personal or family history of allergy, our evaluation at the Sinus and Allergy Wellness Center of North Scottsdale addresses both simultaneously. Nasal endoscopy visualizes the mucosal condition and drainage pathways directly. In-office cone beam CT imaging — reviewed with the patient in the same visit — shows the extent of sinus involvement and the anatomy of the drainage pathways. Allergy assessment — beginning with a targeted history of exposures, seasons, and triggers, followed by allergy skin prick testing when indicated — identifies the specific allergens driving the inflammatory baseline.

Allergy skin prick testing has 85 percent sensitivity and 77 percent specificity for confirming allergic sensitization and is the preferred diagnostic method per the AAO-HNS guideline. For patients who have been sensitized to Arizona-specific allergens — desert broom, olive, mulberry, Bermuda grass, dust mites — identifying the specific allergens allows us to build an immunotherapy program that progressively reduces reactivity over time, lowering the allergic baseline that makes sinus infections recurrent.

Treating the Allergy to Protect the Sinuses

When allergy is identified as a contributing driver of recurrent sinus infections, addressing it is not optional — it is part of the sinus treatment plan. A patient who undergoes balloon sinuplasty to open blocked drainage pathways but continues to have uncontrolled allergic inflammation will eventually re-narrow those pathways through ongoing mucosal swelling. The procedure works with the biology. The biology has to be managed for the procedure to maintain its benefit.

Allergy management at SAWC includes daily intranasal corticosteroid spray as anti-inflammatory foundation, allergen avoidance strategies specific to the Arizona environment, and allergen immunotherapy — subcutaneous injections or sublingual drops — when the degree of sensitization and symptom burden warrants it. Immunotherapy is the only allergy treatment that modifies the underlying immune response rather than managing its symptoms. For patients with significant allergy-driven sinus disease, it is often the piece that finally stops the cycle of recurrent infections that antibiotics alone have never been able to break.

Want to Understand More?

This post is part of the Understanding Your Symptoms series on the Airway & Sinus Wellness Review.

→ Why Antibiotics Keep Failing Your Sinus Infection

→ Is It Possible to Have Sinusitis Without Symptoms of a Cold?

→ Why Do I Keep Getting Sinus Infections After Surgery?

→ Does Balloon Sinuplasty Actually Work?

→ Airway & Sinus Wellness Review — Full Publication

This post is part of the Understanding Your Symptoms section of the Airway & Sinus Wellness Review.

References

1. Payne SC, McKenna M, Buckley J, et al. Clinical Practice Guideline: Adult Sinusitis Update. Otolaryngology–Head and Neck Surgery. 2025. Allergic rhinitis as premorbid CRS factor; prevalence 40–84% in CRS; allergy skin prick test 85% sensitivity, 77% specificity; CCAD. entnet.org

2. Kwah JH, Somani SN, Stevens WW, et al. Clinical factors associated with acute exacerbations of chronic rhinosinusitis. Journal of Allergy and Clinical Immunology. 2020. Allergic rhinitis independently associated with frequent CRS exacerbations (adjusted OR 1.96).

3. Grimm D, Hwang PH, Lin YT. The link between allergic rhinitis and chronic rhinosinusitis. Current Opinion in Otolaryngology & Head and Neck Surgery. 2023. Shared type 2 inflammatory pathways; allergy as premorbid CRS factor.

4. Edwards TS, DelGaudio JM, Levy JM, Wise SK. A prospective analysis of systemic and local aeroallergen sensitivity in central compartment atopic disease. Otolaryngology–Head and Neck Surgery. 2022. 14 of 15 CCAD patients sensitized to at least one allergen; local sensitivities missed by systemic testing.

5. Bernstein JA, Bernstein JS, Makol R, Ward S. Allergic rhinitis: a review. JAMA. 2024. Allergy skin prick test sensitivity and specificity; type 2 inflammatory mechanisms; IgE-mediated mast cell activation.

6. Toppila-Salmi S, Reitsma S, Hox V, et al. Comorbid chronic rhinosinusitis and asthma: shared risk factors and treatment implications. Allergy. 2026. Allergy and CRS overlap; type 2 cytokine pathways; treatment implications.

7. American Academy of Allergy, Asthma & Immunology. Allergic rhinitis — overview and allergen immunotherapy. AAAAI.org

About the Author

Dr. Franklyn R. Gergits, MBA, DO, FAOCO is a Board-Certified Otolaryngologist and Fellowship-Trained Otolaryngic Allergist with a Clinical Focus in Rhinology and Airway Disorders and over 30 years of clinical experience. He is the founder of the Sinus & Allergy Wellness Center of North Scottsdale, where he performs in-office balloon sinuplasty, submucosal partial inferior turbinectomy, NEUROMARK® posterior nasal nerve ablation, and Eustachian tube dilation under local anesthesia. He performed the first balloon sinuplasty in Pennsylvania and holds dual Entellus Centers of Excellence certifications. Dr. Gergits is the originator of the Posterior Sinonasal Syndrome (PSS) hypothesis — a clinical framework identifying pepsin-mediated posterior nasal mucosal injury as an upstream driver of chronic rhinosinusitis. Preprint available at Preprints.org (DOI: 10.20944/preprints202603.0858.v1). ORCID: 0009-0000-4893-6332.

SinusAndAllergyWellnessCenter.com · 480-525-8999

This content is for educational purposes only and does not constitute medical advice. If you have recurrent sinus infections and a history of allergies, consult with a qualified otolaryngologist and allergist for a complete evaluation of both conditions together.

Short answer: Afrin — oxymetazoline — is safe and effective for short-term use of three to five days maximum. After that, it triggers a well-documented cycle called rhinitis medicamentosa — rebound congestion that is worse than the original problem and that drives the patient to use more spray, more often, making the congestion progressively worse. At the Sinus and Allergy Wellness Center of North Scottsdale, rhinitis medicamentosa is one of the most common presentations we see — and almost every patient can be helped off the spray with the right protocol. The key is stopping before the cycle begins, or getting help to break it if it already has.

Why Afrin Works So Well — and Then Stops Working

Afrin works by causing vasoconstriction — it shrinks the vascular structures inside the nose called turbinates, which are lined with erectile tissue that changes size based on blood flow. When the turbinates shrink, the nasal airway opens. Relief is fast, dramatic, and — for the first few days — complete. This is why patients reach for it reflexively. Nothing works faster.

The problem is what happens next. The blood vessels rebound. When vasoconstriction wears off, the vessels dilate wider than they were before the spray. The turbinates swell larger. The congestion is worse than it was before. The patient uses the spray again to get relief. The rebound is worse again. This cycle — rhinitis medicamentosa — typically becomes established within five to seven days of regular use. The FDA label states “do not use for more than 3 days.” The AAO-HNS 2025 guideline and the Rhinitis 2020 parameter allow up to five days — but both emphasize that prolonged use beyond this window causes paradoxical rebound congestion. The safe practical guidance is three days when possible, never beyond five.

One often-overlooked contributor: most oxymetazoline formulations contain benzalkonium chloride as a preservative. Research has confirmed that benzalkonium chloride independently induces mucosal swelling and aggravates rhinitis medicamentosa — meaning the preservative itself, not just the active ingredient, contributes to the rebound cycle. Patients who need short-term topical decongestant use should look for preservative-free oxymetazoline formulations when available.

What Happens in the Body During Rebound Congestion

The mechanism involves two processes operating simultaneously. First, the alpha-adrenergic receptors in the nasal mucosa become desensitized with repeated stimulation — they stop responding to the medication at the same dose, driving the patient toward more frequent use. Second, the mucosa itself becomes inflamed from the repeated vasoconstriction-dilation cycles, adding a genuine inflammatory component on top of the vascular rebound. The result is a nasal lining that is swollen, inflamed, and dependent on the spray to maintain any airway at all.

One pattern patients often notice but rarely connect to Afrin: the congestion is worst at night when lying down. This is not coincidence. When upright, gravity pulls blood toward the legs and abdomen. When lying flat, blood distributes more evenly — more to the head, more to the nose, more to already-engorged turbinates. Patients who are dependent on Afrin cannot sleep without spraying because of this physiology. This disrupted sleep then drives them back to the spray every night.

A 2026 qualitative study found that all six components of Griffiths’ addiction model — salience, mood modification, tolerance, withdrawal, conflict, and relapse — were identifiable in patients with rhinitis medicamentosa. This is not a character flaw. It is a well-documented physiological dependency cycle that is recognized in the behavioral and clinical literature. Patients who feel trapped on Afrin are not imagining the difficulty of stopping — the dependency is real, and so is the help available to break it.

The Three-to-Five Day Rule — and Why It Gets Crossed

Most patients who develop rhinitis medicamentosa did not intend to use Afrin long-term. They used it for a cold, or before a flight, or during a particularly bad allergy week — and it worked so well they continued. The package insert warns against use beyond three days. Most patients do not read it. By the time the dependence is established, stopping feels impossible — one night without the spray means lying awake unable to breathe through the nose, and the spray is right there.

This is one of the most important reasons to treat the underlying cause of nasal congestion rather than relying on Afrin as a maintenance tool. Allergy, chronic sinusitis, a deviated nasal septum, turbinate hypertrophy — all of these cause the congestion that drives patients to Afrin in the first place. Addressing the upstream cause is what prevents the dependence from developing.

If You Are Already Using Afrin Daily — Here Is What to Do

First — if you have been using Afrin daily for less than two weeks, try stopping cold turkey. Sleep with your head elevated. Use high-volume saline irrigation morning and evening. The first three to four nights will be difficult — the rebound congestion at night is significant. Get rid of every bottle in the house so there is no temptation. For most patients who have been using Afrin for a short period, the congestion resolves within one to two weeks of stopping.

If you have been using Afrin for months or years, or if you have tried to stop and failed, a physician-assisted wean is appropriate. At SAWC, Dr. Gergits uses a protocol that may include a tapering oral steroid course to reduce the inflammatory component of the rebound, a transition to intranasal corticosteroid spray, an oral decongestant bridge with pseudoephedrine when appropriate, and in some cases a short course of topical antihistamine spray such as azelastine — particularly when underlying allergy is driving the original congestion. The complete clinical protocol, including patient stories and step-by-step instructions, is detailed in our full post on rhinitis medicamentosa on the Airway & Sinus Wellness Review.

The Serious Risk in Long-Term Users — Septal Perforation

For patients who have used Afrin in both nostrils daily for extended periods, there is a potential structural risk worth understanding. The vasoconstriction caused by oxymetazoline reduces blood flow to the nasal septum. With prolonged bilateral use, the septum — which receives its blood supply from both sides — may be at risk for ischemic tissue injury. Septal perforation has been reported in long-term topical decongestant users, though the direct causal evidence for oxymetazoline specifically is limited and direct clinical studies are sparse. The mechanism is biologically plausible based on the vasoconstrictive action. If you have been using Afrin daily in both nostrils for more than a few weeks, nasal endoscopy in our office can evaluate the septum directly and identify any early changes before they progress.

How Fluticasone Helps Break the Cycle

A key piece of evidence supporting the cessation protocol: a randomized, double-blind, placebo-controlled crossover trial demonstrated that fluticasone nasal spray completely reversed oxymetazoline-induced tachyphylaxis and rebound congestion within three days of use. This is why intranasal corticosteroid spray is a central component of the assisted wean protocol — not just as a long-term anti-inflammatory, but as a pharmacological tool that directly counteracts the rebound mechanism. Starting fluticasone a day or two before stopping Afrin, and continuing it through the first week of cessation, significantly reduces the severity of the withdrawal congestion that drives patients back to the spray.

What to Use Instead of Afrin

Several nasal spray options provide symptom relief without the rebound risk. Intranasal corticosteroid sprays — fluticasone (Flonase), budesonide (Rhinocort), triamcinolone (Nasacort) — reduce inflammation safely with daily use and no rebound potential. They work more slowly than Afrin but address the inflammatory driver rather than temporarily overriding it. Intranasal antihistamine sprays — azelastine (Astepro), olopatadine (Patanase) — are appropriate for allergy-driven congestion and can be used long-term. Intranasal ipratropium (Atrovent Nasal) reduces mucus hypersecretion specifically from nonallergic rhinitis. High-volume saline irrigation is not a spray but is the most evidence-supported first-line intervention for nasal congestion from any cause and carries no rebound risk whatsoever.

Want to Understand More?

This post is part of the Understanding Your Symptoms series on the Airway & Sinus Wellness Review.

→ Rhinitis Medicamentosa — The Complete Clinical Guide to Getting Off Afrin

→ Why Antibiotics Keep Failing Your Sinus Infection

→ Is It Possible to Have Sinusitis Without Symptoms of a Cold?

→ Will Balloon Sinuplasty Help Me Breathe Better?

→ Airway & Sinus Wellness Review — Full Publication

This post is part of the Understanding Your Symptoms section of the Airway & Sinus Wellness Review.

References

1. Payne SC, McKenna M, Buckley J, et al. Clinical Practice Guideline: Adult Sinusitis Update. Otolaryngology–Head and Neck Surgery. 2025. Topical oxymetazoline 3–5 days; rhinitis medicamentosa warning. FDA label: 3 days maximum. entnet.org

2. Dykewicz MS, Wallace DV, Amrol DJ, et al. Rhinitis 2020: a practice parameter update. Journal of Allergy and Clinical Immunology. 2020. RM mechanism; alpha-adrenergic receptor desensitization; up to 5 days use allowed per this parameter.

3. FDA label: oxymetazoline nasal spray. “Do not use for more than 3 days. Frequent or prolonged use may cause nasal congestion to recur or worsen.” Note: AAO-HNS/Rhinitis 2020 allow up to 5 days — FDA label is more conservative. FDA.gov

4. Vaidyanathan S, Williamson P, Clearie K, Khan F, Lipworth B. Fluticasone reverses oxymetazoline-induced tachyphylaxis of response and rebound congestion. Randomized double-blind placebo-controlled crossover trial — complete reversal within 3 days. American Journal of Respiratory and Critical Care Medicine. 2010.

5. Graf P, Hallén H. Benzalkonium chloride in oxymetazoline formulations independently induces mucosal swelling and aggravates rhinitis medicamentosa. Consider preservative-free formulations for short-term use. Clinical and Experimental Allergy. 1996.

6. 2026 qualitative analysis. All six components of Griffiths’ addiction model — salience, mood modification, tolerance, withdrawal, conflict, relapse — identified in rhinitis medicamentosa patients. Journal of Behavioral Addictions. 2026.

7. Lanier B, et al. Nasal septal perforation — causes include intranasal steroid misuse; evidence for oxymetazoline-specific perforation is limited to plausible mechanism and case reports. Annals of Allergy, Asthma & Immunology. 2007.

8. American Academy of Allergy, Asthma & Immunology. Allergic rhinitis — overview. AAAAI.org

About the Author

Dr. Franklyn R. Gergits, MBA, DO, FAOCO is a Board-Certified Otolaryngologist and Fellowship-Trained Otolaryngic Allergist with a Clinical Focus in Rhinology and Airway Disorders and over 30 years of clinical experience. He is the founder of the Sinus & Allergy Wellness Center of North Scottsdale, where he performs in-office balloon sinuplasty, submucosal partial inferior turbinectomy, NEUROMARK® posterior nasal nerve ablation, and Eustachian tube dilation under local anesthesia. He performed the first balloon sinuplasty in Pennsylvania and holds dual Entellus Centers of Excellence certifications. Dr. Gergits is the originator of the Posterior Sinonasal Syndrome (PSS) hypothesis — a clinical framework identifying pepsin-mediated posterior nasal mucosal injury as an upstream driver of chronic rhinosinusitis. Preprint available at Preprints.org (DOI: 10.20944/preprints202603.0858.v1). ORCID: 0009-0000-4893-6332.

SinusAndAllergyWellnessCenter.com · 480-525-8999

This content is for educational purposes only and does not constitute medical advice. If you are dependent on Afrin or another topical decongestant nasal spray, consult with a qualified otolaryngologist for evaluation and a structured cessation protocol.

Short answer: For most patients with chronic sinus symptoms, intranasal corticosteroid sprays — Flonase, Nasacort, Rhinocort — are the best-evidenced starting point. The AAO-HNS gives them a Grade A recommendation based on systematic reviews of randomized controlled trials. They reduce mucosal inflammation, improve sinus drainage, and are safe for long-term daily use with no rebound risk. At the Sinus and Allergy Wellness Center of North Scottsdale, we recommend them to the majority of our patients — but with one critical instruction most patients never receive: use them correctly, because technique determines whether they work. Afrin and other decongestant sprays should never be used beyond five days. Saline spray is inferior to high-volume saline irrigation for sinus problems. This FAQ tells you exactly what to use, what to avoid, and how to use each one correctly.

The Spray That Actually Has the Evidence — Intranasal Corticosteroids

Intranasal corticosteroid sprays are the best-supported pharmacological intervention for chronic sinus and nasal symptoms. The AAO-HNS 2025 Adult Sinusitis Update gives them a Grade A recommendation — the highest level of evidence — for chronic rhinosinusitis. For acute bacterial sinusitis specifically, a Cochrane review found that 54 out of 100 patients using intranasal corticosteroids experienced improvement compared to 49 out of 100 using placebo, with a number needed to treat of approximately eleven. For chronic sinusitis, the effect size is smaller but clinically meaningful — a GRADE network meta-analysis found small-to-moderate improvements in nasal obstruction. An important and striking data point: only 20 percent of patients with chronic rhinosinusitis actually use topical corticosteroids, and most who do use them at inappropriately low doses. This means the majority of CRS patients are undertreating the most evidence-supported intervention available to them.

The most commonly available options over the counter in Scottsdale, Phoenix, and across Arizona are fluticasone propionate (Flonase), budesonide (Rhinocort), triamcinolone (Nasacort), and mometasone furoate (Nasonex 24HR). All four have equivalent evidence for efficacy. They are safe for long-term daily use. Second-generation formulations have systemic bioavailability below one percent — meaning virtually none of the medication enters the bloodstream at recommended doses. They do not cause adrenal suppression. They do not cause rebound congestion.

The most common reason patients say “the nasal spray didn’t work” is incorrect technique. Two technique points make the difference. First — use it after high-volume saline irrigation, not before. Second — aim the nozzle away from the nasal septum, toward the outer wall of the nostril in the direction of the same-side eye. Spraying directly at the septum is both the most common cause of spray-related nosebleeds and the most common reason the medication misses its target. Epistaxis occurs in 4 to 8 percent of patients with short-term use and up to 20 to 28 percent with yearlong daily use — almost entirely preventable with correct technique.

For patients who have already had sinus surgery, or who have moderate-to-severe CRS not controlled by standard spray, budesonide nasal irrigation — adding a budesonide respule to the saline rinse bottle — delivers corticosteroid directly to the sinus mucosa at concentrations higher than a spray can achieve. A 2025 randomized trial found budesonide irrigation produced significantly greater polyp reduction than equivalent-dose budesonide spray (p = 0.003) without HPA-axis suppression. This is a prescription step-up option worth discussing at your evaluation.

The Spray That Should Only Be Used for Three to Five Days — Oxymetazoline (Afrin)

Afrin and other oxymetazoline-based sprays — Vicks Sinex, generic oxymetazoline — provide fast and powerful nasal decongestion by causing vasoconstriction of the turbinate blood vessels. For acute situations — before a flight, during a severe allergy flare, or to temporarily relieve the congestion from a cold — up to five days of use is reasonable. The AAO-HNS specifies three to five days as the maximum before the risk of rhinitis medicamentosa becomes significant.

After five days, the blood vessels rebound — they dilate wider than they were before the spray, causing worse congestion than the original problem. This cycle traps patients in daily use that becomes impossible to break without assistance. Rhinitis medicamentosa is one of the most common presentations at SAWC. If you are currently using Afrin every day, see the companion post on how to stop safely.

The Spray for Allergy-Driven Symptoms — Intranasal Antihistamines

Intranasal antihistamine sprays — azelastine (Astepro, available over the counter) and olopatadine (Patanase, prescription) — work faster than intranasal corticosteroids for allergy symptoms and are more effective than oral antihistamines for nonallergic rhinitis. For patients with symptoms triggered by specific allergen exposures, temperature changes, or irritants — the category of nonallergic or vasomotor rhinitis — intranasal antihistamines are often more effective than intranasal corticosteroids alone. They can also be combined with corticosteroid sprays for patients who need both. Combination sprays containing both an antihistamine and a corticosteroid — Dymista (azelastine plus fluticasone) and Ryaltris (olopatadine plus mometasone) — are available by prescription and provide both mechanisms in a single spray.

The Spray for Mucus Hypersecretion — Ipratropium

Intranasal ipratropium (Atrovent Nasal 0.03%) works through a different mechanism entirely — it blocks parasympathetic nerve stimulation of nasal mucous glands, directly reducing mucus secretion. It is the most appropriate spray for patients with vasomotor rhinitis producing excessive clear mucus triggered by eating, cold air, or other nonallergic stimuli. It does not treat inflammation and is not appropriate as a primary therapy for allergic rhinitis or sinusitis — but for the right patient with the right driver, it is the most targeted option available. A research note: Stanford data shows that patients who respond to ipratropium are significantly more likely to benefit from NEUROMARK® posterior nasal nerve treatment — meaning ipratropium response is a practical predictor of procedural candidacy.

What Not to Use — Phenylephrine Nasal Spray

Phenylephrine nasal spray — Neo-Synephrine and some Sinex formulations — is available over the counter as a topical decongestant. Unlike oral phenylephrine which was ruled ineffective by the FDA in 2023 at its recommended dose, topical phenylephrine does produce local vasoconstriction when applied directly to the mucosa. However, it carries the same rebound risk as oxymetazoline — the same three-to-five day limit applies. Given that oxymetazoline is more potent and longer-acting, there is rarely a clinical reason to choose topical phenylephrine over oxymetazoline when a short-term topical decongestant is genuinely needed.

Saline Spray vs Saline Irrigation — Why the Difference Matters

Saline nasal spray — the small pump bottles that deliver a fine mist — is not the same as high-volume saline irrigation. The AAO-HNS specifically distinguishes these two: high-volume irrigation using a 240ml squeeze bottle is the evidence-supported intervention with a Grade A recommendation. Saline spray delivers a small volume that moisturizes the anterior nasal mucosa and may provide brief comfort but does not flush mucus, allergens, and inflammatory mediators from the nasal cavity the way high-volume irrigation does. If you are using a small saline pump spray for sinus problems, switching to a NeilMed squeeze bottle with twice-daily 240ml rinses will produce meaningfully better results.

The Bottom Line — Which Spray for Which Patient

For chronic sinus symptoms with or without allergy: intranasal corticosteroid spray daily — after saline irrigation, aimed away from the septum. For allergy-dominant symptoms or vasomotor rhinitis: add intranasal antihistamine spray or switch to a combination spray. For mucus hypersecretion from nonallergic triggers: add ipratropium. For acute severe congestion short-term only: oxymetazoline for no more than five days. For long-term nasal hygiene: high-volume saline irrigation — not spray — twice daily.

If you have tried nasal sprays and they have not worked, the most likely explanation is either incorrect technique, the wrong spray for the underlying driver, or an underlying structural or infectious problem that sprays alone cannot address. A nasal endoscopy and CT scan — performed in our office in North Scottsdale in the same visit — give us the information needed to identify what is actually driving your symptoms and match the treatment accordingly.

Want to Understand More?

This post is part of the Understanding Your Symptoms series on the Airway & Sinus Wellness Review.

→ Rhinitis Medicamentosa — The Complete Guide to Getting Off Afrin

→ Why Antibiotics Keep Failing Your Sinus Infection

→ Is It Possible to Have Sinusitis Without Symptoms of a Cold?

→ What Is NEUROMARK® — and Could It Stop Your Chronic Runny Nose?

→ Airway & Sinus Wellness Review — Full Publication

This post is part of the Understanding Your Symptoms section of the Airway & Sinus Wellness Review.

References

1. Payne SC, McKenna M, Buckley J, et al. Clinical Practice Guideline: Adult Sinusitis Update. Otolaryngology–Head and Neck Surgery. 2025. INCS Grade A; high-volume irrigation Grade A; oxymetazoline 3–5 day limit; saline spray vs irrigation distinction; only 20% of CRS patients use INCS at appropriate doses. entnet.org

2. Dykewicz MS, Wallace DV, Amrol DJ, et al. Rhinitis 2020: a practice parameter update. Journal of Allergy and Clinical Immunology. 2020. Intranasal antihistamines for NAR (strong recommendation, high certainty); ipratropium for mucus hypersecretion; combination sprays.

3. Bernstein JA, Bernstein JS, Makol R, Ward S. Allergic rhinitis: a review. JAMA. 2024. INCS first-line; bioavailability <1%; epistaxis 4–8% short-term, 20–28% yearlong; budesonide irrigation more effective than spray post-surgery per NEJM review.

4. Zalmanovici Trestioreanu A, Yaphe J. Cochrane review: intranasal steroids for acute sinusitis. NNT approximately 11; 54 vs 49 per 100 improved — applies to ABRS specifically. Cochrane Database of Systematic Reviews.

5. Chong LY, Head K, Hopkins C, et al. Cochrane review: intranasal steroids for chronic rhinosinusitis. RR 2.74 (95% CI 1.88–4.00) for epistaxis with INCS vs. placebo. Cochrane Database of Systematic Reviews. 2016.

6. Stanford study 2025. Ipratropium responders: 64.7% vs 27.8% meaningful improvement after in-office PNN ablation (p=0.03). Ipratropium response as practical NEUROMARK® candidacy predictor. [Full citation pending publication.]

7. 2025 RCT: budesonide irrigation vs budesonide spray. Significantly greater polyp reduction with irrigation (mLKS Δ4 vs Δ1, p=0.003); no HPA-axis suppression.

8. U.S. Food and Drug Administration. Oral phenylephrine advisory committee: not effective as nasal decongestant at recommended oral dose. September 2023. FDA.gov

About the Author

Dr. Franklyn R. Gergits, MBA, DO, FAOCO is a Board-Certified Otolaryngologist and Fellowship-Trained Otolaryngic Allergist with a Clinical Focus in Rhinology and Airway Disorders and over 30 years of clinical experience. He is the founder of the Sinus & Allergy Wellness Center of North Scottsdale, where he performs in-office balloon sinuplasty, submucosal partial inferior turbinectomy, NEUROMARK® posterior nasal nerve ablation, and Eustachian tube dilation under local anesthesia. He performed the first balloon sinuplasty in Pennsylvania and holds dual Entellus Centers of Excellence certifications. Dr. Gergits is the originator of the Posterior Sinonasal Syndrome (PSS) hypothesis — a clinical framework identifying pepsin-mediated posterior nasal mucosal injury as an upstream driver of chronic rhinosinusitis. Preprint available at Preprints.org (DOI: 10.20944/preprints202603.0858.v1). ORCID: 0009-0000-4893-6332.

SinusAndAllergyWellnessCenter.com · 480-525-8999

This content is for educational purposes only and does not constitute medical advice. If nasal sprays have not resolved your sinus symptoms, consult with a qualified otolaryngologist for a complete evaluation including nasal endoscopy and imaging.

Short answer: That persistent feeling of clogged ears, fullness, muffled hearing, or constant popping is almost always a Eustachian tube problem — not an ear problem. The Eustachian tube connects the middle ear to the back of the nasal cavity, and when it fails to open and close properly, pressure cannot equalize and the result is exactly what you are feeling. In most adults the cause traces upstream to allergy, chronic sinusitis, or laryngopharyngeal reflux driving inflammation at the tube’s nasopharyngeal opening. At the Sinus and Allergy Wellness Center of North Scottsdale, we evaluate and treat ETD in the same visit as sinus disease — because in most patients they share the same upstream driver. For patients who have not responded to medical management, in-office Eustachian tube balloon dilation under local anesthesia is a well-studied option with a 93.6 percent long-term responder rate.

What the Eustachian Tube Does — and Why It Matters

The Eustachian tube is a narrow channel — approximately 35 millimeters long in adults — that connects the middle ear space to the nasopharynx, the area at the very back of the nasal cavity. It serves three essential functions: pressure equalization between the middle ear and the environment, mucociliary clearance of secretions from the middle ear, and protection of the middle ear from pathogens and sound. When all three functions are working, the process is entirely silent and unnoticed. When the tube is dysfunctional, every one of those systems begins to fail simultaneously — and patients feel it as fullness, muffled hearing, popping, or a persistent sense that their ears will not clear.

ETD is far more common than most patients realize. It affects approximately one percent of the general population and over five percent of adults over 65. In the United States it accounts for more than two million adult hospital visits per year — making it one of the most prevalent and most undertreated conditions in ENT practice. Many patients spend years being told to take antihistamines or wait and see, never knowing that a specific structural intervention exists that directly addresses the tube itself.

Why ETD Almost Always Starts in the Nose

The Eustachian tube opens into the nasopharynx — directly adjacent to the posterior nasal cavity. This means that anything causing chronic inflammation, swelling, or dysfunction in the nasal cavity or nasopharynx can directly impair Eustachian tube function. ETD is not primarily an ear disease. It is an upstream airway disease that the ear experiences downstream. Treating the ear in isolation — without identifying and addressing the nasal driver — is why so many patients get only temporary or partial relief.

Allergy is strongly associated with ETD — patients with allergic rhinitis are more than twelve times as likely to develop middle ear dysfunction. In Scottsdale, Phoenix, and the greater Maricopa County area, the extended pollen season and year-round desert allergen burden mean that allergy-driven ETD can be persistent and chronic rather than seasonal. An important nuance for patients: while allergy is associated with ETD, treating it with intranasal corticosteroid sprays has limited direct efficacy for the ETD itself. A 2024 meta-analysis of randomized controlled trials found no significant tympanometric normalization with nasal steroid sprays compared to control, and systematic reviews show they are effective for chronic ETD in only 11 to 18 percent of cases. This does not mean allergy management is unimportant — it means that patients with persistent ETD despite allergy treatment should not simply be told to continue what is not working.

Chronic sinusitis and post-nasal drainage produce continuous mucus pooling in the nasopharynx that bathes the Eustachian tube opening and impairs its normal function. Population data shows that ETD patients are 4.2 times more likely to have chronic sinusitis than the general population. The upstream inflammation driving the sinus disease is almost always the same inflammation driving the ETD — which is why treating both conditions together, in the same visit, produces more complete and durable relief than treating each independently.

Laryngopharyngeal reflux is one of the most consistently overlooked drivers of ETD. Pepsin from the stomach reaching the nasopharynx causes mucosal injury directly at the Eustachian tube opening. Published data shows ETD patients have significantly more nasopharyngeal reflux events than controls — 2.3 versus 0.8 events per study period (p = 0.002) — with reflux finding scores nearly ten times higher (3.6 versus 0.4, p less than 0.001). Reflux symptom severity is independently predictive of poor Eustachian tube patency, and pepsin has been specifically implicated in Eustachian tube dysfunction at the cellular level. ETD patients are 2.4 times more likely to have GERD than the general population. For patients whose ETD does not respond to allergy treatment or sinus management, LPR is often the answer nobody has looked for.

Barometric pressure changes can acutely worsen ETD symptoms in patients whose tubes are already inflamed or dysfunctional. Flying, driving through elevation changes, and rapid weather shifts — especially pre-storm fronts — frequently trigger acute worsening in Scottsdale and Phoenix area patients. The Sonoran Desert’s significant elevation variation and monsoon weather patterns make this a clinically relevant pattern for our patient population.

How ETD Is Evaluated at SAWC

A complete ETD evaluation at the Sinus and Allergy Wellness Center of North Scottsdale includes nasal endoscopy to directly visualize the nasopharynx and the Eustachian tube openings, tympanometry to measure middle ear pressure and eardrum mobility, and audiometry to assess hearing. CT imaging of the sinuses is added when sinus disease is suspected as a contributing factor. Together these studies distinguish obstructive ETD — where the tube fails to open — from patulous ETD, where the tube stays open too much and produces an entirely different set of symptoms. This distinction is critical because the treatments are different, and balloon dilation is specifically indicated for obstructive ETD — not patulous ETD.

The AAO-HNS 2019 Clinical Consensus Statement on Eustachian tube balloon dilation specifies that the diagnosis of obstructive ETD should not be made without comprehensive assessment including otoscopy, audiometry, and nasal endoscopy. That is exactly the standard we apply.

Medical Management — What to Try First

For patients presenting with ETD for the first time or without prior evaluation, medical management is the appropriate starting point. Nasal saline irrigation twice daily, daily intranasal corticosteroid spray, and treatment of underlying allergy or reflux address the upstream drivers that impair Eustachian tube function. Auto-inflation techniques — Valsalva maneuver, or specialized devices like the Otovent — can temporarily open the tube and equalize pressure, providing short-term symptom relief.

Patients should understand, however, that the published evidence for medical therapy in chronic ETD is modest. Only about half of patients experience meaningful improvement with medical management alone, and nasal steroid sprays — the most commonly recommended medical therapy — show limited efficacy in chronic cases. This is not a reason to skip medical management. It is a reason to have an honest conversation about realistic expectations and to establish a clear threshold for when procedural evaluation becomes appropriate.

Eustachian Tube Balloon Dilation — The Structural Solution

For patients whose ETD has not responded adequately to medical management, Eustachian tube balloon dilation is the procedural option recognized by the AAO-HNS 2019 Clinical Consensus Statement as “an option for treatment of patients with obstructive ETD.” A small flexible balloon catheter is passed through the nostril under direct visualization and positioned at the Eustachian tube opening. The balloon is inflated for a defined interval — dilating the tube, creating controlled microfractures in the cartilaginous framework, and remodeling the mucosal tissue in a way that allows the tube to hold open more reliably. The balloon is then deflated and removed. No incisions. No tissue excision. Same-day return to activity.

The long-term outcome data is compelling. A prospective randomized controlled trial showed normalization of validated ETD symptom scores in 56.2 percent of dilation patients versus 8.5 percent of controls at six weeks (p less than 0.001). At a mean follow-up of 29.4 months, 93.6 percent of patients achieved clinically meaningful symptom improvement, the revision rate was only 2.1 percent, and patient satisfaction was 83 percent. A multicenter cohort of 248 patients showed significant improvement sustained at 24 months across all patient subtypes — with the greatest benefit seen in patients whose ETD is triggered by altitude and pressure changes, which is particularly relevant for patients in the Phoenix and Scottsdale area given the frequency of air travel and the region’s elevation profile.

At SAWC, Eustachian tube dilation is performed in the office under local anesthesia — no hospital, no general anesthesia, same-day return to activity. It is frequently performed at the same visit as balloon sinuplasty when both conditions are present, since the upstream inflammation driving sinus disease is almost always the same inflammation driving the ETD. For a complete clinical explanation of exactly what happens during the procedure, the recovery timeline, and what durable results look like — see our full post on Eustachian tube dilation on the Airway & Sinus Wellness Review.

When to Seek Immediate Evaluation

Most ETD is uncomfortable but not urgent. However, sudden hearing loss — any significant drop in hearing that comes on over hours to days — requires same-day or next-day evaluation, as it can represent a separate condition requiring prompt treatment. Ear pain accompanied by high fever, drainage from the ear canal, or significant dizziness with ear symptoms also warrants prompt evaluation rather than watchful waiting.

Want to Understand More?

This post is part of the Understanding Your Symptoms series on the Airway & Sinus Wellness Review.

→ What Eustachian Tube Dilation Actually Does — The Complete Clinical Guide

→ Why Antibiotics Keep Failing Your Sinus Infection

→ Will Balloon Sinuplasty Correct My Post-Nasal Drainage?

→ Does Balloon Sinuplasty Actually Work?

→ Airway & Sinus Wellness Review — Full Publication

This post is part of the Understanding Your Symptoms section of the Airway & Sinus Wellness Review.

References

1. Huisman JML, et al. Cochrane review: Eustachian tube balloon dilation for obstructive ETD. 2025. ~1% general population prevalence; 35mm length; three primary functions; >2 million US adult hospital visits/year.

2. SEER-Medicare database analysis. ETD patients 4.20x more likely to have chronic sinusitis (OR 4.20, 95% CI 3.98–4.43); 2.42x more likely to have GERD (OR 2.42, 95% CI 2.31–2.53); prevalence 5.44% in US adults over 65.

3. Poe DS, et al. Randomized controlled trial: ETDQ-7 normalization 56.2% vs. 8.5% at 6 weeks (p<0.001). AAO-HNS 2019 Clinical Consensus Statement: BDET is “an option for treatment of patients with OETD”; diagnosis requires otoscopy, audiometry, nasal endoscopy.

4. Cutler JL, et al. Long-term balloon ETD outcomes: 93.6% responder rate; 2.1% revision rate; 83% patient satisfaction at mean 29.4 months follow-up. 2019.

5. Sandoval multicenter cohort. 248 patients, 319 ears. Significant improvement sustained at 24 months; greatest benefit in baro-challenge patients; >80% avoidance of repeat tube insertion.

6. 2024 meta-analysis of INCS for ETD. No significant tympanometric normalization with INCS vs. control (OR 1.21, 95% CI 0.65–2.24); effective in only 11–18% of chronic ETD cases.

7. Brunworth JD, et al. LPR-ETD: nasopharyngeal reflux events 2.3 vs. 0.8 (p=0.002); reflux finding scores 3.6 vs. 0.4 (p<0.001); pepsin specifically implicated in ET dysfunction. 2014.

8. Mendelian randomization study. Causal link between allergic rhinitis and nonsuppurative otitis media (OR 12.22, p=0.024).

9. Piccirillo JF, Payne SC, Rosenfeld RM, et al. Clinical Practice Guideline: Adult Sinusitis Update. Otolaryngology–Head and Neck Surgery. 2025. entnet.org

10. Dykewicz MS, Wallace DV, Amrol DJ, et al. Rhinitis 2020: a practice parameter update. Journal of Allergy and Clinical Immunology. 2020.

About the Author

Dr. Franklyn R. Gergits, MBA, DO, FAOCO is a Board-Certified Otolaryngologist and Fellowship-Trained Otolaryngic Allergist with a Clinical Focus in Rhinology and Airway Disorders and over 30 years of clinical experience. He is the founder of the Sinus & Allergy Wellness Center of North Scottsdale, where he performs in-office balloon sinuplasty, submucosal partial inferior turbinectomy, NEUROMARK® posterior nasal nerve ablation, and Eustachian tube dilation under local anesthesia. He performed the first balloon sinuplasty in Pennsylvania and holds dual Entellus Centers of Excellence certifications. Dr. Gergits is the originator of the Posterior Sinonasal Syndrome (PSS) hypothesis — a clinical framework identifying pepsin-mediated posterior nasal mucosal injury as an upstream driver of chronic rhinosinusitis. Preprint available at Preprints.org (DOI: 10.20944/preprints202603.0858.v1). ORCID: 0009-0000-4893-6332.

SinusAndAllergyWellnessCenter.com · 480-525-8999

This content is for educational purposes only and does not constitute medical advice. If you have persistent ear fullness, muffled hearing, or ear popping that has not responded to standard treatment, consult with a qualified otolaryngologist for a complete evaluation including tympanometry and nasal endoscopy.

Short answer: Chronic post-nasal drip is not a diagnosis — it is a symptom with multiple distinct causes. The most common are allergy, nonallergic rhinitis, laryngopharyngeal reflux, and chronic sinusitis. Each requires a different treatment approach, and treating the wrong one produces no improvement. A published three-year study of NEUROMARK® posterior nasal nerve treatment found a 50 percent reduction in post-nasal drainage scores and a 69 percent reduction in cough in patients with posterior nasal nerve-driven drainage. But that treatment is only appropriate when the posterior nasal nerve network is the driver — which is why the evaluation comes first.

What Post-Nasal Drip Actually Is

The nasal mucosa produces mucus continuously — roughly one to two liters per day in a healthy adult. Most of this mucus moves silently backward through the nasal cavity and down the throat via the mucociliary clearance system, where it is swallowed without any awareness. Post-nasal drip occurs when this process becomes abnormal — either because the volume of mucus produced increases, because the character of the mucus changes, because mucociliary clearance is impaired, or because the sensory nerve network of the posterior nasal cavity becomes hypersensitive and registers normal mucus flow as a subjective sensation of drainage.

An important nuance: research suggests that chronic post-nasal drip often involves increased mucus viscosity and impaired mucociliary clearance rather than simply overproduction. A 2019 study found no significant difference in the volume of nasal secretions between patients with post-nasal drip and healthy controls — but viscosity of nasal secretions was significantly increased in PND patients and was reversible during symptom-free intervals. Mucociliary clearance was also prolonged. In practical terms, this means the problem is frequently that mucus is too thick and moves too slowly — not that there is too much of it. This directly explains why hydration, saline irrigation, and treatments that restore normal mucociliary function often provide more relief than medications aimed at reducing mucus production.

That last cause — posterior nasal nerve hypersensitivity — is one of the most clinically significant and least recognized. Patients in this category produce a normal or only slightly elevated volume of mucus, but the posterior nasal nerve network fires in response to that mucus as if there were far more of it. The result is a constant sensation of drainage that is real to the patient but not fully explained by the volume of mucus actually present.

The Most Common Causes — and How to Distinguish Them

Allergy-driven drainage is the most common identifiable cause of chronic post-nasal drip. Allergen exposure triggers mast cell degranulation and release of histamine and other inflammatory mediators that increase mucus production and alter its character. The drainage is typically thin and watery, frequently accompanied by sneezing, nasal itching, and eye symptoms. In Scottsdale, Phoenix, and the greater Maricopa County area, the extended pollen seasons and specific desert allergen profile — desert broom, olive, mulberry, Bermuda grass, and dust mite — keep many patients in a state of near-constant allergic stimulation that drives persistent drainage year-round. This type responds to antihistamines and intranasal corticosteroids when the allergic driver is appropriately identified and treated. One important nuance: up to 50 percent of patients with chronic rhinitis have mixed rhinitis — both allergic and nonallergic components active simultaneously. This explains why many patients get only partial relief from allergy-directed therapy alone and continue to have breakthrough drainage despite appropriate antihistamine or immunotherapy treatment.

Nonallergic or vasomotor rhinitis produces drainage triggered by irritants, temperature changes, humidity shifts, strong odors, and barometric pressure changes rather than allergens. Allergy testing is negative. The drainage is often thick and mucoid rather than thin and watery, and it does not respond to antihistamines the way allergic drainage does. Intranasal antihistamines — azelastine — are more effective for nonallergic rhinitis than oral antihistamines, and intranasal ipratropium can reduce excessive mucus production specifically from this mechanism.

Laryngopharyngeal reflux is a cause that most patients have never been told about. Pepsin from the stomach reaching the posterior nasal cavity triggers mucosal inflammation and increased secretory activity. The drainage produced by LPR tends to be thick, sticky, and difficult to clear — patients frequently describe it as mucus that “never goes anywhere” regardless of how often they clear their throat. The throat clearing itself becomes a habitual response that can persist even after the underlying reflux is treated. LPR is also the most common cause of chronic cough in nonsmoking adults — a connection that most patients never make. Growing evidence including a 2024 systematic review and meta-analysis confirms a significant association between GERD and chronic sinonasal symptoms, with improvement on anti-reflux therapy in the majority of evaluated patients. An important clinical shift: the 2026 San Diego Consensus now recommends upfront objective testing rather than empiric acid suppression alone for isolated laryngopharyngeal symptoms — aligning with our practice’s “evaluation before treatment” philosophy rather than simply starting a PPI and waiting to see what happens.

Chronic sinusitis produces drainage from infected or inflamed sinuses that pools in the nasopharynx. This type is typically associated with other sinus symptoms — congestion, facial pressure, reduced smell — and is confirmed by nasal endoscopy and CT imaging rather than symptoms alone.

Posterior nasal nerve hypersensitivity is the driver for patients whose drainage sensation is disproportionate to the findings on examination and imaging — patients with normal or near-normal endoscopy and CT who still experience significant, life-affecting drainage. This is the patient population where NEUROMARK® posterior nasal nerve treatment is most appropriate and produces the most consistent benefit.

What NEUROMARK® Does — and Who It Helps

NEUROMARK® is an FDA-cleared in-office procedure that uses temperature-controlled radiofrequency energy delivered transnasally to treat the posterior nasal nerve network. These nerves — branches of the vidian nerve and the posterior nasal nerve — control mucus secretion and vascular tone in the posterior nasal cavity. When they become chronically hyperstimulated, the result is persistent drainage, post-nasal drip, and chronic rhinorrhea that does not respond adequately to medications.

A published three-year outcomes study found that NEUROMARK® produced a mean reduction in total nasal symptom scores of 4.5 points from a baseline of 7.8, with rhinorrhea specifically reduced by 55.8 percent and post-nasal drainage scores reduced by 50 percent at three years. Cough — a common downstream consequence of post-nasal drainage, and the most common cause of chronic cough in nonsmoking adults — was reduced by 69 percent. A 2024 systematic review and meta-analysis independently confirmed a pooled responder rate of 77 percent at three months and 81 percent at six months. Approximately 80 percent of appropriately selected patients notice meaningful improvement within the first three to six months.

A practical clinical pearl for patient selection: a 2025 Stanford study found that patients who respond to intranasal ipratropium — a medication that directly targets parasympathetic nerve-driven mucus secretion — had a significantly higher rate of meaningful improvement after in-office posterior nasal nerve ablation compared to non-responders (65 percent vs 28 percent, p = 0.03). If you have tried ipratropium nasal spray and found it helpful, that response may indicate you are a particularly strong candidate for NEUROMARK® and is worth discussing at your evaluation.

The procedure is performed in our office in North Scottsdale under local anesthesia — no hospital, no general anesthesia, same-day return to activity. It is not appropriate for every patient with post-nasal drip. It is most appropriate for patients whose drainage is driven primarily by posterior nasal nerve hypersensitivity — and the evaluation determines who that is.

The Right Sequence — Evaluation Before Treatment

Chronic post-nasal drip that has not responded to antihistamines, nasal sprays, or antibiotics is not treatment-resistant — it is diagnostically incomplete. The cause has not been identified. Nasal endoscopy, CT imaging when indicated, allergy testing, and a careful reflux history are the starting points for distinguishing the drivers and selecting the treatment that is actually right for you.

Want to Understand More?

This post is part of the Understanding Your Symptoms series on the Airway & Sinus Wellness Review.

→ What Is NEUROMARK® — and Could It Stop Your Chronic Runny Nose?

→ Will Balloon Sinuplasty Correct My Post-Nasal Drainage?

→ Why Antibiotics Keep Failing Your Sinus Infection

→ Is It Possible to Have Sinusitis Without Symptoms of a Cold?

→ Airway & Sinus Wellness Review — Full Publication

This post is part of the Understanding Your Symptoms section of the Airway & Sinus Wellness Review.

References

1. Piccirillo JF, Payne SC, Rosenfeld RM, et al. Clinical Practice Guideline: Adult Sinusitis Update. Otolaryngology–Head and Neck Surgery. 2025. entnet.org

2. Three-year NEUROMARK® outcomes data. Mean rTNSS reduction 4.5 points (baseline 7.8); rhinorrhea reduction 55.8%; post-nasal drainage reduction 50%; cough reduction 69%. Responder rate approximately 80% at 3–6 months.

3. Aldajani A, Alhussain F, Mesallam T, et al. Association between chronic rhinosinusitis and reflux diseases in adults: a systematic review and meta-analysis. American Journal of Rhinology & Allergy. 2024. Significant GERD-CRS association; improvement on anti-reflux therapy.

4. Dykewicz MS, Wallace DV, Amrol DJ, et al. Rhinitis 2020: a practice parameter update. Journal of Allergy and Clinical Immunology. 2020. Allergic vs nonallergic rhinitis; treatment distinctions; ipratropium for vasomotor rhinitis.

5. American Academy of Allergy, Asthma & Immunology. Allergic rhinitis — overview. AAAAI.org

6. Gergits FR. Posterior Sinonasal Syndrome (PSS). Preprint DOI: 10.20944/preprints202603.0858.v1. ORCID: 0009-0000-4893-6332.

7. Bucher MR, et al. Post-nasal drip involves increased mucus viscosity and prolonged mucociliary clearance rather than increased secretion volume — reversible during symptom-free intervals. Chest. 2019.

8. Bernstein JA, Bernstein JS, Makol R, Ward S. Allergic rhinitis: a review. JAMA. 2024. Up to 50% of chronic rhinitis patients have mixed allergic and nonallergic components.

9. 2024 systematic review and meta-analysis: radiofrequency neurolysis of the posterior nasal nerve. Pooled responder rate 77.1% at 3 months; 80.8% at 6 months; pooled rTNSS change -4.28 (95% CI -5.10 to -3.46).

10. Stanford study 2025. Ipratropium responders had significantly higher clinically meaningful improvement rate after in-office PNN ablation vs non-responders (64.7% vs 27.8%, p=0.03). Ipratropium response as practical predictor of NEUROMARK® candidacy.

11. 2026 San Diego Consensus. Recommends upfront objective testing rather than empiric PPI trial for isolated laryngopharyngeal symptoms — paradigm shift from empiric acid suppression approach.

About the Author

Dr. Franklyn R. Gergits, MBA, DO, FAOCO is a Board-Certified Otolaryngologist and Fellowship-Trained Otolaryngic Allergist with a Clinical Focus in Rhinology and Airway Disorders and over 30 years of clinical experience. He is the founder of the Sinus & Allergy Wellness Center of North Scottsdale, where he performs in-office balloon sinuplasty, turbinate reduction, NEUROMARK® posterior nasal nerve ablation, and Eustachian tube dilation under local anesthesia. He performed the first balloon sinuplasty in Pennsylvania and holds dual Entellus Centers of Excellence certifications. Dr. Gergits is the originator of the Posterior Sinonasal Syndrome (PSS) hypothesis — a clinical framework identifying pepsin-mediated posterior nasal mucosal injury as an upstream driver of chronic rhinosinusitis. Preprint available at Preprints.org (DOI: 10.20944/preprints202603.0858.v1). ORCID: 0009-0000-4893-6332.

SinusAndAllergyWellnessCenter.com · 480-525-8999

This content is for educational purposes only and does not constitute medical advice. If you have chronic post-nasal drip that has not responded to standard treatment, consult with a qualified otolaryngologist for a complete evaluation of potential underlying drivers.

Short answer: The two OTC interventions with the strongest evidence for sinus symptoms are high-volume nasal saline irrigation and intranasal corticosteroid sprays — both rated Grade A by the AAO-HNS. Pseudoephedrine is an effective oral decongestant available behind the pharmacy counter. Oral phenylephrine — the most common ingredient in products like Sudafed PE and many multi-symptom cold and sinus formulas — was ruled ineffective at its recommended dose by the FDA in 2023 and should be avoided. Oral antihistamines help allergy-driven nasal symptoms but are not recommended for non-allergic sinusitis and may worsen congestion. Pain and pressure respond well to ibuprofen or acetaminophen.

The Most Important Thing to Know Before You Go to the Pharmacy

Most patients with sinus symptoms head to the pharmacy before they see a doctor. That is entirely reasonable — and the right OTC choices can provide meaningful relief and support recovery. The wrong choices provide no benefit at all, and some actively waste money that could be spent on interventions that work. The single most important thing to know before you go: oral phenylephrine — the ingredient in Sudafed PE, DayQuil Sinus, NyQuil Sinus, and hundreds of other multi-symptom products — does not work at the doses available in these products. This is not a new concern. It was confirmed definitively by the FDA in September 2023, when an advisory committee concluded unanimously that oral phenylephrine is not effective as a nasal decongestant at currently approved doses. Despite this ruling, phenylephrine remains widely available on pharmacy shelves. Check the active ingredients on any sinus or cold product before purchasing.

What Actually Works — Nasal Saline Irrigation

High-volume nasal saline irrigation is the single most evidence-based OTC intervention available for sinus symptoms. The AAO-HNS 2025 guideline gives it a Grade A recommendation — the highest level of evidence — based on systematic reviews of randomized controlled trials. It works by physically flushing inflammatory mediators, allergens, pathogens, and thick mucus from the nasal cavity and sinus drainage pathways. It is not a placebo effect. It is mechanical removal of the material driving your symptoms.

The key word is high-volume. A nasal spray bottle delivering a fine mist does not accomplish the same thing as a 240ml squeeze bottle like NeilMed Sinus Rinse that delivers a sustained flow of saline through the nasal cavity. Use it twice daily — morning and evening. Use it before your nasal corticosteroid spray, not after, so the spray reaches mucosa that has been cleared rather than mucosa still coated with debris. Saline rinse kits are available at any pharmacy for a few dollars and can be refilled with saline packets indefinitely. For patients in Scottsdale, Phoenix, and the greater Arizona area, the dry desert climate makes consistent irrigation particularly important — low humidity thickens nasal secretions and impairs mucociliary clearance significantly.

Critical safety point: Always use distilled, bottled, or previously boiled water — never tap water directly from the faucet. Tap water can contain organisms including Naegleria fowleri, a rare but potentially fatal amoeba that can cause brain infection when introduced through the nasal passages. The AAO-HNS specifically names this risk. Distilled water from any grocery store is the safest and most practical choice.

What Actually Works — Intranasal Corticosteroid Sprays

Intranasal corticosteroid sprays — fluticasone (Flonase), budesonide (Rhinocort), triamcinolone (Nasacort), and mometasone (Nasonex 24HR) — are all available over the counter and all have strong evidence supporting their use for sinus and allergy symptoms. The AAO-HNS gives them a Grade A recommendation as well. They reduce mucosal swelling, decrease inflammatory mediator production, and — with consistent daily use — significantly improve both nasal airflow and sinus drainage.

Two important points about how to use them correctly. First, use them every day — not as needed. These sprays take several days to reach full effect and require consistent daily use to maintain it. Using them only on bad days provides minimal benefit. Second, use them after your saline rinse, not before. Spraying into a nasal cavity still coated with mucus and debris reduces both the absorption and the efficacy of the medication. Rinse first, then spray.

These sprays are safe for long-term use. Second-generation formulations have systemic bioavailability below one percent — meaning virtually none of the medication enters the bloodstream at recommended doses. They do not cause adrenal suppression or systemic steroid side effects at OTC doses used correctly. The most common side effect is epistaxis — nosebleeds — occurring in 4 to 8 percent of patients with short-term use and up to 20 to 28 percent with yearlong use. To minimize this risk, aim the spray away from the nasal septum and toward the outer wall of the nostril — roughly in the direction of the middle of the same-side eye. Spraying directly onto the septum is the most common cause of spray-related nosebleeds.

Pseudoephedrine — The Decongestant That Works

Pseudoephedrine is the oral decongestant with the best available evidence for nasal congestion relief. It works by causing vasoconstriction in the nasal mucosa, reducing swelling and improving airflow. It is available without a prescription but is kept behind the pharmacy counter due to regulations about purchase quantity — you will need to show ID and sign for it. The AAO-HNS notes that recent large RCT evidence specifically for sinusitis is limited, though pseudoephedrine is the standard of care for oral decongestant therapy when one is indicated.

Use it with caution or avoid it entirely if you have heart disease, uncontrolled hypertension, cardiac arrhythmia, glaucoma, hyperthyroidism, or bladder outlet obstruction — a relevant consideration for older male patients with prostate enlargement. Avoid during the first trimester of pregnancy. A meta-analysis of 24 trials found the mean blood pressure increase from pseudoephedrine is modest — approximately one millimeter of mercury systolic — in most patients with controlled hypertension, though rare idiosyncratic reactions can occur. Check with your pharmacist or physician before use. Do not use it as a long-term solution — it addresses congestion but does not treat the underlying driver of sinus disease.

What Does Not Work — Oral Phenylephrine

Oral phenylephrine is the active decongestant ingredient in Sudafed PE and the vast majority of multi-symptom sinus and cold combination products sold at standard pharmacy shelves — the ones you can pick up without going to the pharmacist. In September 2023, an FDA advisory committee voted unanimously that oral phenylephrine is not effective as a nasal decongestant at the doses in these products. The conclusion was based on a comprehensive review of clinical trial data showing that phenylephrine is extensively metabolized in the gut before reaching the nasal mucosa, resulting in insufficient systemic concentrations to produce a decongestant effect.

This means that a significant portion of the sinus medication aisle at any pharmacy is selling products with an ineffective active ingredient. Read labels. If the decongestant ingredient is phenylephrine — avoid it. If the decongestant ingredient is pseudoephedrine — that is the one that works.

Topical Nasal Decongestants — Oxymetazoline (Afrin) — Use Sparingly

Oxymetazoline — sold as Afrin and in many generic nasal spray decongestants — provides faster and more potent nasal decongestion than oral pseudoephedrine. The AAO-HNS recommends it as an option for short-term congestion relief. It works directly on the nasal mucosa, shrinking swollen blood vessels within minutes and opening the nasal airway rapidly.

The critical warning: do not use it for more than three to five days. This is not a guideline suggestion — it is the FDA-mandated label warning. Prolonged use causes rhinitis medicamentosa — rebound congestion that is worse than what you started with. When the spray wears off, the blood vessels dilate beyond their original size, causing severe congestion that drives the patient to use more spray, creating a dependency cycle that can persist for months. We see this regularly in our office in North Scottsdale — patients who have been using Afrin daily for months or years because they cannot breathe without it. Breaking the cycle requires stopping the spray, often with the help of an intranasal corticosteroid to manage the rebound, and occasionally a short steroid course. The same cardiovascular cautions that apply to pseudoephedrine apply to oxymetazoline — use with caution in patients with heart disease, uncontrolled hypertension, or thyroid disease.

Antihistamines — Helpful for Allergy, Not for Sinusitis

Non-sedating antihistamines — loratadine (Claritin), cetirizine (Zyrtec), fexofenadine (Allegra) — are appropriate and effective for allergy-driven nasal symptoms including sneezing, itching, and runny nose. If your sinus symptoms are clearly allergy-related or if you have a known allergy history, adding an antihistamine is reasonable.

However, the AAO-HNS explicitly states that antihistamines have no role in the symptomatic relief of bacterial sinusitis in non-allergic patients, and that they may worsen congestion by drying the nasal mucosa. If your symptoms are driven by sinusitis rather than allergy — or if you are unsure — antihistamines are not the answer and may make drainage more difficult.

One important warning: avoid older, first-generation antihistamines — diphenhydramine (Benadryl), chlorpheniramine, and similar products. These cause significant sedation, dry the nasal and sinus mucosa, and are not recommended for sinus symptoms. They are particularly problematic in older adults. Stick to the second-generation options listed above.

Guaifenesin (Mucinex) — What the Evidence Actually Shows

Guaifenesin is one of the most widely purchased OTC sinus products — marketed as an expectorant to thin and loosen mucus. Many patients take it routinely during sinus flares. The AAO-HNS 2025 guideline states directly that guaifenesin “is sometimes recommended to ‘loosen’ nasal discharge, but there is no evidence regarding the effect, if any, on symptomatic relief” of sinusitis. The American College of Chest Physicians has stated that guaifenesin is ineffective as an expectorant. A 2024 review in Otolaryngology–Head and Neck Surgery highlighted the lack of significant benefits over placebo for upper respiratory disease.

Guaifenesin is unlikely to cause harm — but there is no evidence-based reason to recommend it for sinus symptoms. If you have been taking it and feel it helps, the available evidence suggests the benefit is likely from staying well-hydrated alongside the medication rather than from the guaifenesin itself. Save your money for the interventions that have evidence behind them.

Pain and Pressure — Ibuprofen vs Acetaminophen

Both ibuprofen and acetaminophen provide meaningful relief of sinus pain and pressure — but they have complementary rather than identical benefits. The AAO-HNS guideline notes that acetaminophen may help relieve nasal obstruction and rhinorrhea, while ibuprofen and other NSAIDs are better for headache, facial pain, malaise, and ear pain. For patients without NSAID contraindications, ibuprofen is generally preferred when headache and facial pain are the dominant complaints. Acetaminophen is the appropriate choice when congestion and drainage relief is the primary goal, and is safer for patients with gastric sensitivity, anticoagulation therapy, or renal concerns. Alternating both can provide broader coverage across the full symptom spectrum. Do not exceed recommended daily limits for either medication.

Want to Understand More?

This post is part of the Understanding Your Symptoms series on the Airway & Sinus Wellness Review.

→ Why Antibiotics Keep Failing Your Sinus Infection

→ Is It Possible to Have Sinusitis Without Symptoms of a Cold?

→ Why Do I Keep Getting Sinus Infections After Surgery?

→ Does Balloon Sinuplasty Actually Work?

→ Airway & Sinus Wellness Review — Full Publication

This post is part of the Understanding Your Symptoms section of the Airway & Sinus Wellness Review.

References

1. Piccirillo JF, Payne SC, Rosenfeld RM, et al. Clinical Practice Guideline: Adult Sinusitis Update. Otolaryngology–Head and Neck Surgery. 2025. Saline irrigation Grade A; INCS Grade A; antihistamines not recommended for non-allergic sinusitis. entnet.org

2. U.S. Food and Drug Administration. FDA advisory committee concludes oral phenylephrine is not effective as nasal decongestant. September 2023. FDA.gov

3. Dykewicz MS, Wallace DV, Amrol DJ, et al. Rhinitis 2020: a practice parameter update. Journal of Allergy and Clinical Immunology. 2020. Pseudoephedrine safety qualifiers; antihistamine use in allergic vs nonallergic rhinitis.

4. Chow AW, Benninger MS, Brook I, et al. IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis. Clinical Infectious Diseases. 2012. idsociety.org

5. Cochrane Collaboration. Saline nasal irrigation for acute upper respiratory tract infections. Grade A evidence for symptom relief and mucociliary function.

6. Centers for Disease Control and Prevention. Antibiotic prescribing and use — sinus infection. OTC guidance. CDC.gov

7. Rudmik L, Soler ZM. Medical therapies for adult chronic sinusitis: a systematic review. JAMA. 2015. A-I grade for saline irrigation; INCS NNT=11 across all doses.

8. Salerno SM, Jackson JL, Berbano EP. Effect of oral pseudoephedrine on blood pressure and heart rate: a meta-analysis. JAMA Internal Medicine. 2005. Mean SBP increase 0.99 mmHg; modest cardiovascular effect in most patients.

9. Meltzer EO, Ratner PH, McGraw T. Oral phenylephrine HCl for nasal congestion in seasonal allergic rhinitis: a randomized, open-label, placebo-controlled study. JACI in Practice. 2015. 539 patients; phenylephrine up to 40mg not better than placebo.

10. Eyassu M, McCoul ED. Guaifenesin for upper respiratory disease: lack of significant benefits over placebo. Otolaryngology–Head and Neck Surgery. 2024. No evidence of efficacy for sinusitis or expectorant benefit.

About the Author

Dr. Franklyn R. Gergits, MBA, DO, FAOCO is a Board-Certified Otolaryngologist and Fellowship-Trained Otolaryngic Allergist with a Clinical Focus in Rhinology and Airway Disorders and over 30 years of clinical experience. He is the founder of the Sinus & Allergy Wellness Center of North Scottsdale, where he performs in-office balloon sinuplasty, turbinate reduction, NEUROMARK® posterior nasal nerve ablation, and Eustachian tube dilation under local anesthesia. He performed the first balloon sinuplasty in Pennsylvania and holds dual Entellus Centers of Excellence certifications. Dr. Gergits is the originator of the Posterior Sinonasal Syndrome (PSS) hypothesis — a clinical framework identifying pepsin-mediated posterior nasal mucosal injury as an upstream driver of chronic rhinosinusitis. Preprint available at Preprints.org (DOI: 10.20944/preprints202603.0858.v1). ORCID: 0009-0000-4893-6332.

SinusAndAllergyWellnessCenter.com · 480-525-8999

This content is for educational purposes only and does not constitute medical advice. Before starting any OTC medication for sinus symptoms, consult with a qualified physician or pharmacist — particularly if you have cardiovascular disease, hypertension, or are taking prescription medications.

Short answer: Yes — and it is more common than most patients realize. Sinusitis does not require a viral cold to develop. Allergy, laryngopharyngeal reflux, anatomical obstruction, and immune dysregulation can all drive chronic sinus inflammation silently — without fever, facial pain, or any symptom the patient would recognize as a sinus problem. Many patients with chronic sinusitis have been living with their symptoms so long they have become their baseline. A nasal endoscopy and CT scan often reveal what years of unrecognized symptoms could not.

We see this in our clinic regularly. A patient comes in after having an imaging study of the head done for a completely unrelated reason — a headache evaluation, a dental issue, something that had nothing to do with their sinuses. And right there on the scan, clear as day, is evidence of sinusitis. The patient had no idea. No cold. No facial pain. No congestion they were aware of. Nothing they would have called a sinus problem.

An important note before we go further: not every incidental sinus finding on imaging represents disease that needs treatment. Mucosal changes on CT or MRI are common even in people without sinus symptoms — studies show that 12 to 15 percent of genuinely asymptomatic individuals have significant sinus findings on imaging. The key is whether those findings correlate with your symptoms and what nasal endoscopy shows. Imaging alone cannot confirm a diagnosis of chronic sinusitis. That is exactly why a complete evaluation matters.

So how does sinusitis develop without a cold?

A Viral Cold Is Just One of Many Triggers

The most common assumption patients make is that sinusitis starts with a cold — a viral upper respiratory infection that spreads into the sinuses. And that does happen. But a virus is just one of many upstream triggers that can drive sinus inflammation. It is not even close to the only one.

Allergy is one of the most common drivers of chronic sinusitis — present in 40 to 84 percent of CRS patients — and many patients with significant allergic sensitization have never been properly tested. Allergy skin prick testing is the preferred confirmatory method. In Scottsdale, Phoenix, and the greater Maricopa County area, the allergen burden is significant and year-round, with desert broom, olive, mulberry, Bermuda grass, and dust mite exposures extending across more months than most patients realize.

Environmental exposures are a driver that research now quantifies with precision. Every microgram per cubic meter increase in PM2.5 air pollution is associated with a ten percent increase in CRS-related medical visits. A large UK Biobank study of 367,298 participants found that long-term PM2.5 exposure increased CRS risk by 59 percent. Arizona’s air quality — particularly in the Phoenix metro area during high-wind and pre-monsoon periods — makes this a clinically relevant consideration for patients in our area.

Laryngopharyngeal reflux — pepsin from the stomach reaching the posterior nasal cavity — is a driver that most patients have never heard of and that most physicians outside our specialty rarely evaluate. Growing evidence suggests that pepsin triggers an inflammatory response in the posterior nasal mucosa that looks and feels like sinusitis. Importantly, research shows that LPR alone can produce significant sinus symptoms without any endoscopic evidence of sinusitis — meaning some patients with “silent sinusitis” do not have sinus disease at all. The problem is upstream.

Dental infections are another common non-viral cause of sinusitis that is frequently overlooked. Studies estimate that dental sources account for 10 to 40 percent of maxillary sinusitis cases. An infected tooth, a failed root canal, or a dental implant near the floor of the maxillary sinus can drive sinus inflammation directly and persistently — without any cold, any allergy, and any other sinus trigger. If your sinus symptoms are primarily one-sided and you have had recent dental work or dental pain, this connection should be evaluated.

Immune dysregulation is a driver seen in a meaningful subset of patients. In some patients the immune system is underactive — failing to clear pathogens adequately — due to immunoglobulin deficiency. Studies show that 13 to 23 percent of patients with refractory chronic rhinosinusitis have a measurable immunoglobulin deficiency. In others the immune system is overactive, driving mucosal inflammation without any infectious trigger. Either pattern can sustain chronic sinus inflammation silently.

Anatomical problems — a deviated septum, narrowed drainage pathways, or structural variants — can create the conditions for chronic mucosal inflammation that builds silently over months or years. None of these require a cold to get started.

A note on migraine: Some patients who believe they have chronic sinusitis without cold symptoms actually have migraine. Migraine activates the trigeminal system, producing genuine nasal congestion, drainage, and facial pressure through parasympathetic pathways. If nasal endoscopy and CT are both normal but symptoms persist — migraine belongs in the evaluation before any further sinus-directed treatment is pursued.

Why Some Patients Have No Symptoms — and Why Some Truly Do Not

This is the part that surprises patients most. When I sit down with someone who has just been handed a CT scan showing sinusitis they knew nothing about, they almost always ask the same question: if my sinuses are inflamed, why don’t I feel it?

For many patients, the honest answer is that they probably do feel it — they just do not recognize it as a sinus problem. The congestion they write off as normal. The post-nasal drainage they have learned to clear without thinking about it. The slight reduction in their sense of smell they attribute to getting older. The morning fatigue they blame on poor sleep. The mild facial pressure they dismiss as tension. These patients have been living with their symptoms so long that the symptoms have become their baseline. They have no reference point for what normal actually feels like.

But — and this matters — some patients with incidental imaging findings truly are asymptomatic. Not every sinus finding on imaging means a problem that needs to be fixed. What determines whether treatment is needed is the correlation between the imaging findings, the nasal endoscopy, and the symptom history. If the imaging shows mucosal changes but the endoscopy is normal and the patient has no relevant symptoms, watchful waiting may be entirely appropriate. When I tell a patient “you probably have no idea how much better you could feel,” I mean patients in whom the symptom picture and the objective findings align. Not every incidental scan finding is that patient.

Red Flags That Need Urgent Evaluation

Whether or not a cold preceded your symptoms, certain findings always warrant prompt evaluation: one-sided sinus symptoms only, bloody or rust-colored nasal discharge, progressive facial pain or swelling, vision changes, or new neurological symptoms. These can indicate something other than chronic inflammatory sinusitis — including dental pathology, neoplasm, or vascular causes — and require specialist assessment without delay.

What This Means for Your Care

If you have been told incidentally that your sinuses show inflammation on imaging — or if you suspect that what you have been calling your normal is actually chronic sinus disease that has never been properly evaluated — a nasal endoscopy and a complete review of your history is the right next step.

The goal is to identify which upstream driver is active in your case. Treatment matched to the actual cause gets results. Treating the sinuses while the upstream driver continues unaddressed is why so many patients cycle through repeated courses of antibiotics or have sinus procedures with incomplete long-term relief. The sinuses are often the victim. The driver is upstream — and finding it changes everything.

Want to Understand More?

This post is part of the Understanding Your Symptoms series on the Airway & Sinus Wellness Review.

→ Why Antibiotics Keep Failing Your Sinus Infection

→ Can Sinusitis Cause Daily Headaches?

→ The Final Chapter: What the Field Still Cannot See — Posterior Sinonasal Syndrome

→ Airway & Sinus Wellness Review — Full Publication

This post is part of the Understanding Your Symptoms section of the Airway & Sinus Wellness Review.

References

1. Piccirillo JF, Payne SC, Rosenfeld RM, et al. Clinical Practice Guideline: Adult Sinusitis Update. Otolaryngology–Head and Neck Surgery. 2025. entnet.org

2. Fokkens WJ, Lund VJ, Hopkins C, et al. European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS) 2020. Rhinology. 2020.

3. Aldajani A, Alhussain F, Mesallam T, et al. Association between chronic rhinosinusitis and reflux diseases in adults: a systematic review and meta-analysis. American Journal of Rhinology & Allergy. 2024.

4. Hamilos DL. Chronic rhinosinusitis: epidemiology and medical management. Journal of Allergy and Clinical Immunology. 2011.

5. American Academy of Allergy, Asthma & Immunology. Allergic rhinitis and sinusitis overview. AAAAI.org

6. Razi CH, et al. Systematic review of incidental sinus findings in asymptomatic individuals: mean LM score 2.24; 14.71% with LM ≥4. Otolaryngology–Head and Neck Surgery. 2022.

7. Meiklejohn DA, Tummala N, Lalakea ML. Climate change, allergic rhinitis, and sinusitis. JAMA. 2025. PM2.5 associated with 10% increase in CRS visits per µg/m³.

8. Zhou Q, Ma J, Biswal S, et al. Air pollution, genetic factors, and chronic rhinosinusitis. Science of the Total Environment. 2024. HR 1.59 for long-term PM2.5 exposure in UK Biobank cohort of 367,298.

9. Keating MK, Phillips JC. Chronic Rhinosinusitis. American Family Physician. 2023. Odontogenic sinusitis 10–40% of maxillary cases; migraine in differential. AAFP.org

About the Author

Dr. Franklyn R. Gergits, MBA, DO, FAOCO is a Board-Certified Otolaryngologist and Fellowship-Trained Otolaryngic Allergist with a Clinical Focus in Rhinology and Airway Disorders and over 30 years of clinical experience. He is the founder of the Sinus & Allergy Wellness Center of North Scottsdale, where he performs in-office balloon sinuplasty, turbinate reduction, NEUROMARK® posterior nasal nerve ablation, and Eustachian tube dilation under local anesthesia. He performed the first balloon sinuplasty in Pennsylvania and holds dual Entellus Centers of Excellence certifications. Dr. Gergits is the originator of the Posterior Sinonasal Syndrome (PSS) hypothesis — a clinical framework identifying pepsin-mediated posterior nasal mucosal injury as an upstream driver of chronic rhinosinusitis. Preprint available at Preprints.org (DOI: 10.20944/preprints202603.0858.v1). ORCID: 0009-0000-4893-6332.

SinusAndAllergyWellnessCenter.com · 480-525-8999

This content is for educational purposes only and does not constitute medical advice. If you have been told you have sinusitis on imaging or suspect you may have undiagnosed sinus disease, consult with a qualified otolaryngologist for a complete evaluation.

Short answer: Start with high-volume saline irrigation twice daily, a daily intranasal corticosteroid spray, and supportive care. If symptoms have not improved after ten days, if you have had two or more similar episodes in the past year, or if antibiotics have already failed you — stop managing at home and get a proper evaluation. That means nasal endoscopy and a CT scan, not another empiric antibiotic prescription. Most sinus symptoms do not require antibiotics. What they require is an accurate diagnosis — and that is where most patients are being failed.

This is exactly the right question to ask before you do anything else — because what you do first matters more than most people realize. The most common first response to sinus symptoms is an antibiotic. And in most cases, it is the wrong call. Not because your doctor is wrong, but because the diagnosis has not been confirmed yet.

Here is how to think through this properly.

First — Confirm That You Actually Have Sinusitis

Sinusitis means inflammation of the sinuses — and it has a specific symptom pattern. You are looking for nasal obstruction or congestion, discolored nasal drainage, facial pressure or fullness, and reduced sense of smell. The key timing marker: symptoms lasting more than ten days without improvement, or symptoms that improve and then suddenly worsen.

If your symptoms started less than ten days ago and are getting better, this is most likely a viral upper respiratory infection. It will resolve on its own. An antibiotic will not help it and may cause harm by disrupting the bacterial balance in your sinuses. Patience and supportive care are the right moves at this stage.

You also want to consider your allergy history. Many patients who believe they have recurrent sinus infections are actually experiencing undertreated allergic rhinitis — chronic nasal inflammation driven by allergens rather than infection. If you have a known allergy history, that context is important before any treatment decision is made. Note that nonallergic or vasomotor rhinitis — nasal congestion and pressure driven by irritants, temperature changes, or other non-allergic triggers — is a distinct condition that is less responsive to nasal corticosteroids and requires a different treatment approach.

Could It Be Migraine — Not Sinusitis?

This is the question that most patients with chronic sinus pressure have never been asked. Studies consistently show that 50 to 80 percent of patients presenting with what they or their physician call a “sinus headache” actually have migraine. A landmark study found that 88 percent of patients with self-reported or physician-diagnosed “sinus headache” met criteria for migraine. The mechanism is well understood: migraine activates the trigeminovascular system, producing genuine nasal symptoms — congestion, rhinorrhea, and facial pressure — through parasympathetic activation. These patients feel real sinus pressure. Their sinuses are not the problem.

The features that point toward migraine rather than sinusitis: nausea during the pressure episode, sensitivity to light or sound, sensitivity to smells, and a normal nasal endoscopy and CT scan. If your sinus pressure has never fully responded to antibiotics, antihistamines, or nasal sprays — and particularly if it tracks with weather changes — migraine belongs in the conversation before any further sinus-directed treatment is pursued.

What to Do Right Now at Home

Start with high-volume nasal saline irrigation — 240ml twice daily using a squeeze bottle like NeilMed. This is the single most evidence-based first step you can take. It physically removes inflammatory mediators, allergens, and pathogens from the nasal mucosa. It costs almost nothing and has no downside.

Add a daily intranasal corticosteroid spray — fluticasone (Flonase), budesonide (Rhinocort), or triamcinolone (Nasacort) are all available over the counter. Use it every day, not as needed. These reduce mucosal swelling and are appropriate whether your problem is sinusitis, allergic rhinitis, or both.

For congestion, pseudoephedrine — available behind the pharmacy counter without a prescription — can open the nasal passages and improve drainage. Use with caution if you have heart disease, uncontrolled hypertension, or glaucoma — check with your pharmacist or physician first. For facial pain and pressure, ibuprofen or acetaminophen provide meaningful relief. If you have known seasonal allergies, adding a non-sedating antihistamine such as loratadine or cetirizine is appropriate — note that antihistamines are not recommended for sinus symptoms in patients without allergic disease as they may worsen congestion.

Stay well-hydrated. Adequate hydration may help keep mucus thinner and more mobile, particularly in dry climates like Arizona. There is no specific fluid formula supported by the clinical evidence — general adequate daily hydration is a reasonable goal.

When to Stop Managing at Home and See a Specialist

If your symptoms have not improved after ten days of the above, if you have had two or more similar episodes in the past year, or if you have already been prescribed antibiotics with no lasting relief — it is time for a proper evaluation. That means nasal endoscopy and a CT scan of the sinuses. These two studies together confirm whether chronic rhinosinusitis is present, how extensive it is, and what is driving it.

Do not accept another empiric antibiotic without a culture first. Most antibiotic prescriptions for sinus complaints are written without one, which means the treatment is a guess. A rhinologist can confirm the diagnosis, identify what is actually driving your symptoms — whether that is anatomy, allergy, immune dysregulation, or something upstream like silent reflux — and match the treatment to the actual cause rather than the assumed one.

When to Seek Immediate Care

Most sinus symptoms are uncomfortable but not dangerous. However, certain symptoms require emergency evaluation rather than a scheduled appointment — periorbital swelling or redness around the eye, double vision or any change in vision, severe headache that is different from your usual headaches, high fever with facial pain, new neurological symptoms, or nosebleeds that will not stop. These can indicate a complication of sinusitis that requires urgent treatment. Do not wait for these to resolve on their own.

Want to Understand More?

This post is part of the Understanding Your Symptoms series on the Airway & Sinus Wellness Review.

→Why Antibiotics Keep Failing Your Sinus Infection

→Can Sinusitis Cause Daily Headaches?

→Why Do I Keep Getting Sinus Infections After Surgery?

→Airway & Sinus Wellness Review — Full Publication

This post is part of the Understanding Your Symptoms section of the Airway & Sinus Wellness Review.

References

1. Piccirillo JF, Payne SC, Rosenfeld RM, et al. Clinical Practice Guideline: Adult Sinusitis Update. Otolaryngology–Head and Neck Surgery. 2025. entnet.org

2. Schreiber CP, Hutchinson S, Webster CJ, et al. Prevalence of migraine in patients with a history of self-reported or physician-diagnosed “sinus” headache. Archives of Internal Medicine. 2004. 88% met migraine criteria.

3. Bernichi JV, Rizzo VL, Villa JF, et al. Rhinogenic and sinus headache — literature review. American Journal of Otolaryngology. 2021. 50–80% of “sinus headache” is migraine.

4. Chow AW, Benninger MS, Brook I, et al. IDSA Clinical Practice Guideline for Acute Bacterial Rhinosinusitis. Clinical Infectious Diseases. 2012. idsociety.org

5. Centers for Disease Control and Prevention. Antibiotic prescribing and use — sinus infection. CDC.gov

6. Keating MK, Phillips JC. Chronic Rhinosinusitis. American Family Physician. 2023. AAFP.org Alarm symptoms and urgent referral criteria.

7. Bernstein JA, Bernstein JS, Makol R, Ward S. Allergic rhinitis: a review. JAMA. 2024. Allergic vs nonallergic rhinitis distinction; pseudoephedrine safety qualifiers.

About the Author

Dr. Franklyn R. Gergits, MBA, DO, FAOCO is a Board-Certified Otolaryngologist and Fellowship-Trained Otolaryngic Allergist with a Clinical Focus in Rhinology and Airway Disorders and over 30 years of clinical experience. He is the founder of the Sinus & Allergy Wellness Center of North Scottsdale, where he performs in-office balloon sinuplasty, turbinate reduction, NEUROMARK® posterior nasal nerve ablation, and Eustachian tube dilation under local anesthesia. He performed the first balloon sinuplasty in Pennsylvania and holds dual Entellus Centers of Excellence certifications. Dr. Gergits is the originator of the Posterior Sinonasal Syndrome (PSS) hypothesis — a clinical framework identifying pepsin-mediated posterior nasal mucosal injury as an upstream driver of chronic rhinosinusitis. Preprint available at Preprints.org (DOI: 10.20944/preprints202603.0858.v1). ORCID: 0009-0000-4893-6332.

SinusAndAllergyWellnessCenter.com · 480-525-8999

This content is for educational purposes only and does not constitute medical advice. If you are experiencing severe symptoms including orbital swelling, high fever, vision changes, or stiff neck, seek immediate medical care.

1. What Is Nasal & Airway Endoscopy?

Nasal and airway endoscopy is a direct examination of the inside of the nose, sinus drainage pathways, nasopharynx, and upper airway using a small camera — called an endoscope — passed gently through the nostril. The camera transmits live images to a monitor in the exam room, allowing us to see the nasal anatomy, mucosal condition, and any structural or inflammatory findings in real time.

The endoscope can be rigid or flexible depending on what we are evaluating. A rigid endoscope provides higher resolution images and is used for detailed nasal and sinus evaluation. A flexible scope allows us to navigate around curves in the airway and evaluate the nasopharynx, the back of the nasal cavity, the vocal cords, and the structures of the upper airway. In many cases we use both during the same visit.

2. Why Would I Need Nasal & Airway Endoscopy?

Because looking inside the nose is not the same as looking at the nose. A standard examination — holding a light at the nostrils and looking in — shows only the very front of the nasal cavity. Nasal endoscopy lets us see the middle meatus, the sinus drainage pathways, the posterior nasal cavity, the nasopharynx, and the structures that standard examination simply cannot reach.

At the Sinus and Allergy Wellness Center of North Scottsdale, we perform nasal endoscopy on every patient because the information it provides is not optional — it is the foundation of everything we recommend. You cannot identify the cause of a patient’s symptoms without looking at the anatomy and mucosal condition directly. Guessing from symptoms alone is how patients end up on repeated antibiotic courses that never fully work.

3. Is the Procedure Painful?

No. Nasal endoscopy is not painful. Before the scope is passed, we apply a topical decongestant and anesthetic spray to the nasal lining — this opens the nasal passages slightly and numbs the mucosa so that the examination is comfortable. Most patients describe the sensation as mild pressure or a slight awareness that something is present. It is not the experience most people fear before they have it.

The procedure takes a matter of minutes. There is no recovery time and no restriction on activity afterward. Patients drive themselves home, return to work, and resume their normal day immediately after the examination.

4. How Long Does the Examination Take?

The examination itself typically takes five to ten minutes. When combined with our standard evaluation — history, global examination, and CT review if imaging has been obtained — the total nasal endoscopy portion of your visit is a small fraction of the time we spend together. The images are captured and reviewed with you during the same appointment. There is no waiting for results.

5. Will My Nose Be Numbed?

Yes. We apply a topical decongestant and anesthetic spray to both nasal passages before the examination begins. This serves two purposes — it reduces any discomfort during the procedure, and it opens the nasal passages by reducing mucosal swelling, which improves our view and allows the scope to pass more comfortably. The numbing effect is temporary and wears off within thirty to sixty minutes after the examination.

6. What Can Endoscopy Show?

This is where the fascination begins — for us and for our patients. Most people have never seen inside their own nose. When the endoscope passes through the nasal cavity and the images appear on the monitor, patients almost universally lean forward. What they see for the first time is the anatomy that has been driving their symptoms — often for years.

Nasal endoscopy can show active infection — mucopurulent drainage in the middle meatus or nasopharynx that is directly visible and can be suctioned clear and sampled for molecular diagnostic testing through MicroGenDX in the same moment. It can show nasal polyps blocking the nasal airway and the sinus drainage pathways. It can show a deviated nasal septum causing significant airway obstruction. It can show turbinate hypertrophy, mucosal edema from allergy or inflammation, posterior nasal drainage, and the condition of the nasopharynx and Eustachian tube openings. These are not abstract findings described in a report — they are images the patient sees with their own eyes. That changes the conversation entirely.

7. Can Endoscopy Detect Nasal Polyps?

Yes — and nasal polyps are one of the most powerful findings in terms of patient understanding. When a patient who has been struggling to breathe through their nose sees a polyp on the monitor — a pale, grape-like mass occupying part of the nasal airway — the question of why breathing has been difficult answers itself. There is no ambiguity. No report to interpret. The patient sees what is blocking their airway and understands immediately why it needs to be addressed.

Endoscopy identifies the location, size, and extent of polyp disease. When combined with CT imaging, this gives us a complete picture of how extensively the polyps are affecting the sinus drainage pathways — information that is essential for treatment planning.

8. Can Endoscopy Show a Sinus Infection?

Yes. Active sinus infection produces mucopurulent drainage that collects at the sinus drainage pathways — particularly the middle meatus, where the maxillary, anterior ethmoid, and frontal sinuses all drain. This drainage is directly visible on endoscopy. We can see it, suction it clear, and obtain a targeted specimen for molecular diagnostic testing through MicroGenDX in the same examination — without requiring a separate procedure or a second visit.

This is one of the most important clinical advantages of endoscopy-directed culture. The specimen comes from exactly the right location — the drainage pathway of the affected sinus — rather than a general nasal swab that may not accurately reflect what is happening inside the sinuses themselves. The yield is higher. The result is more clinically meaningful. And the antibiotic decision that follows is based on what the patient actually has, not what we assume they have.

9. Can Endoscopy Explain Post-Nasal Drainage?

Yes — and it frequently identifies the source that patients have never had explained to them. Post-nasal drainage that pools in the nasopharynx, drains across the posterior nasal nerve network, and irritates the throat and airway is directly visible on endoscopy. We can see where the drainage is originating, assess the condition of the posterior nasal mucosa, and evaluate whether the Eustachian tube openings are affected.

For patients with chronic post-nasal drainage, this posterior view is often the most revealing part of the entire examination — because it is the area most commonly overlooked in a standard ENT visit where the scope does not go far enough back to see it.

10. Can Endoscopy Evaluate My Vocal Cords?

Yes. Using a flexible laryngoscope passed through the nose, we can visualize the vocal cords directly. This is performed in the office, in the same exam room, without sedation. The vocal cords are viewed in real time as they open and close during breathing and phonation. We assess their mobility, their mucosal condition, and whether any structural or inflammatory changes are present that could be contributing to voice symptoms.

11. Can Endoscopy Help Determine the Cause of Hoarseness?

Yes — flexible laryngoscopy is the primary diagnostic tool for evaluating hoarseness. Hoarseness can be caused by vocal cord nodules, polyps, cysts, paralysis, laryngopharyngeal reflux causing mucosal irritation of the larynx, or other structural changes. None of these can be identified without direct visualization. Endoscopy provides that visualization in minutes, in the office, without the need for a separate procedure or referral to a different facility.

For patients in Scottsdale and the greater Phoenix area whose hoarseness has been attributed to allergies or acid reflux without direct visualization of the vocal cords, endoscopy frequently provides the first objective look at what is actually present — and changes the treatment accordingly.

12. Can Endoscopy Evaluate Chronic Cough or Throat Clearing?

Yes. Chronic cough and chronic throat clearing are among the most common complaints we evaluate with endoscopy — because their causes are frequently visible on examination. Post-nasal drainage irritating the posterior pharynx, laryngopharyngeal reflux causing mucosal changes in the larynx and hypopharynx, vocal cord irritation, and posterior nasal nerve overactivity are all conditions that produce cough and throat clearing and that endoscopy can directly assess.

Patients who have been treated for chronic cough with acid suppression or allergy medications without improvement often have an airway-level driver that has never been visualized. Endoscopy is how we find it.

13. Can Endoscopy Identify the Cause of Nosebleeds?

Yes. Recurrent nosebleeds — epistaxis — are frequently caused by dilated blood vessels on the nasal septum in a region called Kiesselbach’s plexus, but they can also originate from other locations in the nasal cavity including the posterior nasal cavity where bleeding can be more difficult to control. Endoscopy allows us to visualize the entire nasal cavity including posterior locations that anterior rhinoscopy cannot reach, identify the source of bleeding, and assess whether treatment — including in-office cauterization — is appropriate.

14. Is Endoscopy Safe?

Yes. Nasal endoscopy is one of the most commonly performed procedures in otolaryngology and has an excellent safety profile. Serious complications are exceptionally rare. The most common side effect is mild temporary nasal discomfort or, occasionally, very minor bleeding from the nasal mucosa during the examination — both of which resolve quickly without intervention. The topical anesthetic and decongestant we use before the procedure significantly reduce the likelihood of either.

The procedure is performed thousands of times daily in ENT offices across the country. At SAWC, it is a standard part of every patient evaluation — not an add-on, not a separate procedure visit, and not something that requires advance preparation or recovery time.

15. Will I Be Able to See the Images During My Visit?

Yes — always. Seeing the images is not a bonus at SAWC. It is the standard. As the endoscope passes through your nasal cavity, the images appear on the monitor in the exam room in real time. You watch the examination as it happens. We narrate what we are seeing. We point out the findings. We explain what they mean for your symptoms and your treatment options.

For most patients, this is the first time they have ever seen inside their own nose — and what they see answers questions they have been asking for years. The deviated septum that has been making it hard to breathe. The polyps that have been blocking their airway. The infection draining from a sinus that no antibiotic has fully cleared. These are not abstract diagnoses anymore. They are images on a screen, explained in plain language, by the physician who is going to help you resolve them.

That is what we mean by See. Understand. Resolve. — and it starts the moment the endoscope enters the nasal cavity.

Want to Understand More?

This post is part of the Understanding Your Symptoms series on the Airway & Sinus Wellness Review.

→ What Is MicroGenDX — and Why Does It Change How We Treat Sinus Infections?

→ Why Antibiotics Keep Failing Your Sinus Infection

→ Will Balloon Sinuplasty Correct My Post-Nasal Drainage?

→ What Is NEUROMARK® — and Could It Stop Your Chronic Runny Nose for Good?

→ Airway & Sinus Wellness Review — Full Publication

This post is part of the Understanding Your Symptoms section of the Airway & Sinus Wellness Review.

About the Author

Dr. Franklyn R. Gergits, MBA, DO, FAOCO is a Board-Certified Otolaryngologist and Fellowship-Trained Otolaryngic Allergist with a Clinical Focus in Rhinology and Airway Disorders and over 30 years of clinical experience. He is the founder of the Sinus & Allergy Wellness Center of North Scottsdale, where he performs in-office balloon sinuplasty, turbinate reduction, NEUROMARK® posterior nasal nerve ablation, and Eustachian tube dilation under local anesthesia. He performed the first balloon sinuplasty in Pennsylvania and holds dual Entellus Centers of Excellence certifications. Dr. Gergits is the originator of the Posterior Sinonasal Syndrome (PSS) hypothesis — a clinical framework identifying pepsin-mediated posterior nasal mucosal injury as an upstream driver of chronic rhinosinusitis. Preprint available at Preprints.org (DOI: 10.20944/preprints202603.0858.v1). ORCID: 0009-0000-4893-6332.

SinusAndAllergyWellnessCenter.com · 480-525-8999

This content is for educational purposes only and does not constitute medical advice. If you are experiencing nasal, sinus, or airway symptoms and would like a comprehensive evaluation including nasal endoscopy, consult with a qualified otolaryngologist for individualized assessment and treatment recommendations.

Short answer: A sinus CT scan shows the complete three-dimensional anatomy of your nasal cavity and sinuses — including whether sinuses are blocked, inflamed, or infected, whether a deviated septum or structural abnormality is contributing to your symptoms, and whether nasal polyps are present. It is information that nasal endoscopy alone cannot provide, and at the Sinus and Allergy Wellness Center of North Scottsdale, we review it with you directly — on the monitor, in the exam room, in real time. See. Understand. Resolve.

1. What Does a Sinus CT Scan Show?

A sinus CT scan is like the key piece of a puzzle that makes everything else fall into place. Once it goes in, the whole picture comes together quickly. It shows us the complete anatomy of your nasal cavity and all of your paranasal sinuses — the maxillary sinuses behind your cheekbones, the ethmoid sinuses between your eyes, the frontal sinuses above your eyebrows, and the sphenoid sinuses deep at the base of the skull.

Specifically, we are looking at whether the sinus drainage pathways are open or obstructed, whether there is mucosal thickening indicating inflammation, whether fluid or infection is present inside any sinus cavity, whether structural factors like a deviated septum or enlarged turbinates are narrowing the airway, and whether nasal polyps or other soft tissue changes are contributing to blockage. Every patient’s scan is different — and that is exactly the point. The CT scan tells us what is actually happening in your sinuses, not what we assume is happening based on symptoms alone.

2. Why Would I Need a CT Scan?

Even with nasal endoscopy — which lets us look directly inside the nose — we still cannot see inside the sinuses themselves. The nose can appear relatively normal on endoscopy while the sinuses harbor significant disease that only CT reveals. The reverse is also true — a nose that looks inflamed on endoscopy may have sinuses that are largely clear. Without the CT scan, we are making decisions with incomplete information.

There is a second reason the CT scan matters that most patients never hear: when we are considering obtaining a specimen for molecular diagnostic testing through MicroGenDX, the CT scan directs us to the exact sinus showing the most significant disease. That targeted approach increases the yield of the culture dramatically — meaning we are more likely to identify the organism driving the infection and less likely to miss it by sampling the wrong location.

3. Is a CT Scan Safe?

Yes — and our in-office CT system makes the safety answer even stronger. At SAWC we use the J. Morita cone beam CT scanner, which is one of the gold standard imaging systems used in ENT and maxillofacial imaging. Cone beam CT delivers significantly less radiation than conventional CT — typically 0.1 to 0.6 millisieverts depending on the field of view, compared to 0.6 to 1.0 millisieverts for a conventional sinus CT. The radiation dose from our unit is low enough that radiation engineers cleared the installation without requiring lead-lined walls or ceiling. That is not a common statement — and it tells you something meaningful about the dose involved.

The scan itself takes less than a minute. There is no injection, no contrast dye, and no claustrophobia concern. For patients with chronic sinus disease who may need imaging more than once over the course of their care, the cumulative dose remains well within accepted safety parameters.

4. How Much Radiation Is Used?

Our J. Morita cone beam CT delivers approximately 0.1 to 0.6 millisieverts of radiation depending on the field of view selected for your specific evaluation. For comparison, a cross-country flight exposes you to roughly 0.02 to 0.05 millisieverts of cosmic radiation. A conventional chest X-ray delivers approximately 0.1 millisieverts. A conventional sinus CT at a hospital or imaging center delivers 0.6 to 1.0 millisieverts.

Our cone beam technology produces high-resolution three-dimensional imaging of the nasal cavity, sinuses, and surrounding structures at a lower radiation dose than conventional CT. The diagnostic information it provides is exceptional — and the radiation exposure involved is among the lowest available for this type of imaging.

5. Can a CT Scan Show Why I Keep Getting Sinus Infections?

Yes — and this is one of the most important questions the CT scan can answer. Recurrent sinus infections are almost never random. There is almost always a structural or anatomical reason why certain sinuses are repeatedly affected. The CT scan shows us whether a drainage pathway is chronically narrowed, whether a structural variant is predisposing a particular sinus to obstruction, whether there is evidence of chronic mucosal disease that has never fully resolved between episodes, and whether chronic mucosal changes suggestive of persistent or biofilm-related infection are present.

For patients who have been through multiple antibiotic courses with only temporary relief, the CT scan is often the first time anyone has looked at the structural picture. What it reveals frequently explains everything.

6. Can a CT Scan Explain Why I Cannot Breathe Through My Nose?

Absolutely. Nasal obstruction has many potential drivers — a deviated nasal septum, inferior turbinate hypertrophy, swell body enlargement, nasal polyps, chronic mucosal edema from allergy or inflammation, or combinations of all of the above. The CT scan maps all of these simultaneously, showing us not just that obstruction is present but exactly where it is coming from and how significant each contributing factor is.

This matters because the treatment for a deviated septum is different from the treatment for turbinate hypertrophy, which is different from the treatment for nasal polyps. Knowing precisely what is driving the obstruction allows us to target the treatment rather than guess at it.

7. Will Insurance Cover My CT Scan?

In most cases, yes — when the scan is ordered for an appropriate clinical indication such as chronic sinusitis, recurrent acute sinusitis, nasal obstruction, or evaluation prior to a procedure. Coverage does vary by plan, and prior authorization may be required by some insurers. Our team reviews your insurance coverage before the scan is performed and discusses any expected out-of-pocket costs with you in advance. We respect your time and your finances — there are no surprises.

8. How Long Does a CT Scan Take?

The actual scan takes less than one minute. The total time from when you sit down at the scanner to when you return to the exam room is typically five to ten minutes. This includes positioning, the scan itself, and image reconstruction. There is no preparation required, no recovery time, and no restriction on activity afterward. You will be reviewing your results with us within minutes of the scan being completed.

9. Do I Need Special Preparation?

No special preparation is required for a standard sinus CT scan. You do not need to fast, stop medications, or do anything differently before your appointment. If you wear glasses or jewelry near the head and neck area, you will be asked to remove them briefly for the scan. That is the extent of the preparation involved.

10. What Happens After My CT Scan?

This is where SAWC is fundamentally different from the standard model of care. After your CT scan is completed, our staff returns you to your exam room. Your images are loaded on the monitor directly in front of you. We sit down together and we review them with you — not a radiologist’s report read to you by a provider who may or may not have seen the images themselves. You see what we see. We explain what we are looking at in plain language. We answer your questions. We ask you questions. And then we develop a plan together.

The standard model — order the CT at visit one, send the patient to an imaging center, schedule a second appointment to review the report, possibly refer to a third provider — means three visits, three missed blocks of time from work, more delay, and more uncertainty. We collapse that entire sequence into one appointment. That is our commitment to you.

11. Can a CT Scan Detect Nasal Polyps?

Yes. Nasal polyps — benign inflammatory growths that develop from the nasal and sinus mucosa — are clearly visible on CT imaging. The scan shows their location, their size, and how extensively they are affecting the sinus drainage pathways. This information is essential for treatment planning, as polyp disease often requires a different approach than sinusitis without polyps, and the extent of disease on CT is one of the factors that guides whether medical management alone or a procedural intervention is the appropriate next step.

12. Can a CT Scan Detect a Deviated Septum?

Yes — and in more detail than a physical examination alone. The CT scan shows the full length and contour of the nasal septum from the tip of the nose to the nasopharynx, including deviations that may not be fully appreciated on anterior rhinoscopy. It also shows whether the deviation is affecting the sinus drainage pathways or contributing to turbinate compensation on the opposite side — both of which are clinically important for treatment decisions. Most patients assume they have a deviated septum. The CT scan tells us whether it is actually contributing to their symptoms.

13. Will I Review the Images During My Visit?

Yes — always. Reviewing the CT scan with you is not optional at SAWC. It is the standard. You sit in front of the monitor. We go through the images together. We point out what we see. We explain what it means. We give you the chance to ask every question you have before we discuss treatment options. This is not how most ENT practices operate — but it is how we operate, because we believe that a patient who understands what is happening in their own sinuses is a better partner in their own care.

14. Can CT Imaging Help Determine Whether I Need a Procedure?

Yes — it is one of the primary tools we use to make that determination. The CT scan shows us whether sinus drainage pathways are obstructed in a way that would benefit from balloon sinuplasty, whether turbinate hypertrophy is severe enough to warrant reduction, whether polyp burden is significant enough to change the treatment approach, and whether the anatomy is suitable for in-office intervention under local anesthesia. It takes the guesswork out of the decision and replaces it with objective information. We do not recommend procedures based on symptoms alone. We recommend them based on what we can see.

15. Is CT Imaging Performed in the Office?

Yes. At the Sinus and Allergy Wellness Center of North Scottsdale, CT imaging is performed in-office using a J. Morita cone beam CT scanner — one of the gold standard systems used in ENT and maxillofacial imaging. It produces high-resolution three-dimensional images of the nasal cavity, sinuses, and surrounding structures at a radiation dose low enough that our installation was cleared by radiation engineers without requiring lead-lined walls or ceiling.

You do not need to drive to a separate imaging center, wait for a report, or schedule a follow-up appointment to discuss results. The scan is done here, reviewed here, and discussed here — on the same visit, in the same exam room, with the same provider who examined you. This is what we mean by respecting your time. And it is what we mean by See. Understand. Resolve.

Want to Understand More?

This post is part of the Understanding Your Symptoms series on the Airway & Sinus Wellness Review.

→ Why Antibiotics Keep Failing Your Sinus Infection

→ What Is MicroGenDX — and Why Does It Change How We Treat Sinus Infections?

→ Does Balloon Sinuplasty Actually Work?

→ Is It Possible to Have Sinusitis Without Symptoms of a Cold?

→ Airway & Sinus Wellness Review — Full Publication

This post is part of the Understanding Your Symptoms section of the Airway & Sinus Wellness Review.

About the Author

Dr. Franklyn R. Gergits, MBA, DO, FAOCO is a Board-Certified Otolaryngologist and Fellowship-Trained Otolaryngic Allergist with a Clinical Focus in Rhinology and Airway Disorders and over 30 years of clinical experience. He is the founder of the Sinus & Allergy Wellness Center of North Scottsdale, where he performs in-office balloon sinuplasty, turbinate reduction, NEUROMARK® posterior nasal nerve ablation, and Eustachian tube dilation under local anesthesia. He performed the first balloon sinuplasty in Pennsylvania and holds dual Entellus Centers of Excellence certifications. Dr. Gergits is the originator of the Posterior Sinonasal Syndrome (PSS) hypothesis — a clinical framework identifying pepsin-mediated posterior nasal mucosal injury as an upstream driver of chronic rhinosinusitis. Preprint available at Preprints.org (DOI: 10.20944/preprints202603.0858.v1). ORCID: 0009-0000-4893-6332.

SinusAndAllergyWellnessCenter.com · 480-525-8999

This content is for educational purposes only and does not constitute medical advice. If you have questions about whether a sinus CT scan is appropriate for your symptoms, consult with a qualified otolaryngologist for individualized evaluation and recommendations.

More Than a Routine Office Visit

I think of what we do at the Sinus and Allergy Wellness Center of North Scottsdale as being the Sherlock Holmes of our trade. A comprehensive ENT evaluation is not a quick look and a prescription. It is a methodical, layered process of gathering information — from the history, from the examination, from what we see on endoscopy — and assembling it into a complete picture of what is actually driving your symptoms.

Most patients who come to us have already been to other physicians. They have had their symptoms acknowledged. They have been given treatments that worked partially or not at all. What they have not had is someone sit down and ask the questions that go beyond the intake form. That is where we start.

The Detailed History — Where the Real Answers Begin

Before we examine anything, we want to know your story. Not just the chief complaint — but the full context. When did symptoms start? What makes them better? What makes them worse? What treatments have you tried and what happened? What does a typical day feel like? Are there patterns — morning versus evening, indoor versus outdoor, certain seasons, certain exposures?

The intake form captures the basics. The conversation captures what the form cannot. Patients often tell us things in conversation that they did not think to write down — a pattern, a trigger, a detail that turns out to be the most important piece of information in the entire visit. We ask because we want to know. Not because we have to. Because that information is what separates a diagnosis from a guess.

The Two-Stage Examination — Global Then Deep Dive

Our examination approach is deliberately two-stage. The first examination is global — a complete assessment of the ears, nose, throat, head, and neck. We are looking at everything. We are not yet focused on one area. We want the full picture before we narrow our attention.

The second examination is the deep dive. This is where we go back into the areas that matter most for the question you came in to answer. Why did you schedule this appointment? What is the symptom that has been driving your life? That is the question we are trying to answer in the secondary examination — and we answer it with nasal endoscopy, with direct visualization, with the tools that let us see what is actually happening rather than infer it from symptoms alone.

This two-stage approach is what allows us to catch things that a single-pass examination misses. The secondary examination is not a repeat of the first — it is a targeted investigation informed by everything we learned in the first.

See. Understand. Resolve.

This is the philosophy that drives every evaluation we perform. It is not enough to tell a patient what is wrong. We want you to see it. When we find something on nasal endoscopy, we show you. When the CT scan reveals a pattern, we explain it in plain language. When the allergy results come back, we translate them into what they mean for your daily life.

Most patients leave a standard ENT visit knowing they were examined. Our patients leave knowing what was found, why it matters, and what the options are. That distinction changes the entire treatment relationship — because when you understand what is happening in your own body, you become an active participant in your care rather than a passive recipient of someone else’s decisions.

A Treatment Plan With You — Not For You

Once we have completed the evaluation and explained what we found, we develop a treatment plan together. Your input matters. Your preferences matter. Your tolerance for different approaches matters. Your life circumstances matter.

We do not walk into the room with a predetermined plan. We walk in with findings, options, and a genuine interest in what you think — because you are going to be the one living with the treatment decision. Reaching common ground with our patients is not just good medicine. It is what produces the best outcomes. When patients understand what they are doing and why, they follow through. And when they follow through, good things follow.

What We Do That Others Do Not

The secondary examination — the deep dive — is the piece that most distinguishes our approach. It is not standard practice. Most ENT offices perform a single comprehensive examination and move to recommendations. We go back. We look again. We look specifically at what your symptoms are pointing toward and we look until we have an answer worth giving you.

Patient education is the other differentiator. We believe that a well-informed patient is a better patient — better able to participate in their care, better able to recognize when something is improving or not, better able to communicate what they are experiencing. That is why we built this publication. That is why we explain everything we find. That is why we invite you to look through the endoscope when we do. Because seeing is believing — and believing is the foundation of getting better.

Want to Understand More?

This post is part of the Understanding Your Symptoms series on the Airway & Sinus Wellness Review.

→ Is It Possible to Have Sinusitis Without Symptoms of a Cold?

→ Why Antibiotics Keep Failing Your Sinus Infection

→ What Is MicroGenDX — and Why Does It Change How We Treat Sinus Infections?

→ Does Balloon Sinuplasty Actually Work?

→ Airway & Sinus Wellness Review — Full Publication

This post is part of the Understanding Your Symptoms section of the Airway & Sinus Wellness Review.

About the Author

Dr. Franklyn R. Gergits, MBA, DO, FAOCO is a Board-Certified Otolaryngologist and Fellowship-Trained Otolaryngic Allergist with a Clinical Focus in Rhinology and Airway Disorders and over 30 years of clinical experience. He is the founder of the Sinus & Allergy Wellness Center of North Scottsdale, where he performs in-office balloon sinuplasty, turbinate reduction, NEUROMARK® posterior nasal nerve ablation, and Eustachian tube dilation under local anesthesia. He performed the first balloon sinuplasty in Pennsylvania and holds dual Entellus Centers of Excellence certifications. Dr. Gergits is the originator of the Posterior Sinonasal Syndrome (PSS) hypothesis — a clinical framework identifying pepsin-mediated posterior nasal mucosal injury as an upstream driver of chronic rhinosinusitis. Preprint available at Preprints.org (DOI: 10.20944/preprints202603.0858.v1). ORCID: 0009-0000-4893-6332.

SinusAndAllergyWellnessCenter.com · 480-525-8999

This content is for educational purposes only and does not constitute medical advice. If you are experiencing ENT symptoms and would like a comprehensive evaluation, consult with a qualified otolaryngologist for individualized assessment and treatment recommendations.

Short answer: Morning congestion is almost never caused by a single factor. The most common drivers are nasal anatomy — a deviated septum or turbinate hypertrophy that worsens when you lie down — combined with allergy, environmental exposures, or underlying sinus inflammation. When blood redistributes to the nasal tissues during sleep, any existing obstruction becomes more pronounced. Identifying and treating the specific driver — not just managing the symptom — is what produces lasting relief.

The First Thing I Think About — Nasal Airway Anatomy

When a patient tells me they wake up congested every morning, the first thing I am thinking about is anatomy. Does this patient have a deviated nasal septum? Is there turbinate hypertrophy — enlargement of the nasal turbinates — that worsens when they lie down at night?

This is where the blood flow redistribution explanation becomes important. When you are upright during the day, gravity helps keep blood from pooling in the nasal tissues. When you lie down at night, that blood redistributes. The turbinates — the three paired structures inside each nasal cavity that warm, filter, and humidify the air you breathe — can engorge with blood during sleep. If they are already enlarged from chronic inflammation, allergy, or anatomy, that engorgement pushes them further into the airway. The resistance to breathing through the nose increases. You wake up congested.

For patients with significant inferior turbinate hypertrophy or a deviated septum contributing to that obstruction, this is not just a nuisance — it is a nightly cycle that compounds over time.

What We Look For Inside the Nose

Beyond the turbinates, nasal endoscopy gives us a direct view of everything that contributes to nighttime and morning obstruction. We look for anatomical factors — a deviated septum, concha bullosa, Haller cells, swell body hypertrophy — as well as inflammatory findings like mucosal edema, polyps, post-nasal discharge, and evidence of chronic rhinosinusitis.

Each of these findings adds to the total resistance of nasal breathing. A patient with a mild septal deviation who also has turbinate hypertrophy and allergic mucosal edema is experiencing the combined effect of all three simultaneously. Treating one while the others remain unaddressed is why so many patients feel only partial improvement from any single intervention.

The Allergy Connection — Especially in Arizona

Allergy history is always part of the conversation. Perennial allergic rhinitis — allergy driven by year-round exposures like dust mites, pet dander, and mold — produces chronic mucosal inflammation that does not vary much with the seasons. Patients with perennial allergy often notice their worst symptoms in the morning precisely because nighttime exposure to bedroom allergens — dust mites in bedding, pet dander, mold in humid rooms — has been building for hours while they slept.

In Scottsdale and the greater Phoenix area, the allergen burden is significant and extends across more of the year than most patients realize. We are not a low-allergen environment. Desert broom, olive, mulberry, and Bermuda grass produce heavy pollen loads across extended seasons. If allergy is driving your morning congestion, managing it with antihistamines alone — without addressing the mucosal inflammation — is unlikely to produce meaningful improvement.

What Nighttime Congestion Does to the Rest of Your Health

This is the part most patients have not connected. When nasal obstruction worsens at night, the body compensates by opening the mouth to breathe. Mouth breathing is inefficient — the nose warms, filters, and humidifies inspired air in ways the mouth cannot replicate. The inspired air is drier and less conditioned. The throat and mouth dry out. Discomfort builds. And mouth breathing at night is directly associated with snoring and, in susceptible patients, with worsening obstructive sleep apnea.

Patients who present to us with morning congestion frequently also report non-restorative sleep, morning fatigue, dry mouth, and sore throat — all downstream consequences of a nasal airway that is not functioning efficiently during the hours when the body depends on it most.

What to Try Before You See Us — and What We Do When You Do

Before an evaluation, the most evidence-based first steps are high-volume nasal saline irrigation twice daily — 240ml with a squeeze bottle — followed by a daily intranasal corticosteroid spray. The spray should be used after the rinse, not before, and it should be used daily — not as needed. If allergy is suspected, adding a non-sedating antihistamine and reviewing bedroom allergen controls — mattress covers, HEPA filtration, pet exclusion from the bedroom — is worth doing simultaneously.

If those measures do not produce meaningful improvement within four to six weeks, a complete nasal evaluation is the next step. At the Sinus & Allergy Wellness Center of North Scottsdale, that means nasal endoscopy to visualize the anatomy and mucosal condition directly, allergy evaluation when indicated, and a treatment plan matched to what we actually find — not a presumed diagnosis based on symptoms alone.

For patients with significant turbinate hypertrophy contributing to nighttime obstruction, turbinate reduction performed in the office under local anesthesia is often transformative. For patients with a deviated septum adding structural resistance, that can be addressed as well. The goal is to restore normal nasal airway function so the body can do what it is designed to do during sleep — breathe efficiently, without compensation.

Want to Understand More?

This post is part of the Understanding Your Symptoms series on the Airway & Sinus Wellness Review.

→ Will My Snoring Resolve With Balloon Sinuplasty?

→ Will My Obstructive Sleep Apnea Be Cured After Balloon Sinuplasty?

→ Will Balloon Sinuplasty Help Me Breathe Better?

→ Is It Possible to Have Sinusitis Without Symptoms of a Cold?

→ Airway & Sinus Wellness Review — Full Publication

This post is part of the Understanding Your Symptoms section of the Airway & Sinus Wellness Review.

About the Author

Dr. Franklyn R. Gergits, MBA, DO, FAOCO is a Board-Certified Otolaryngologist and Fellowship-Trained Otolaryngic Allergist with a Clinical Focus in Rhinology and Airway Disorders and over 30 years of clinical experience. He is the founder of the Sinus & Allergy Wellness Center of North Scottsdale, where he performs in-office balloon sinuplasty, turbinate reduction, NEUROMARK® posterior nasal nerve ablation, and Eustachian tube dilation under local anesthesia. He performed the first balloon sinuplasty in Pennsylvania and holds dual Entellus Centers of Excellence certifications. Dr. Gergits is the originator of the Posterior Sinonasal Syndrome (PSS) hypothesis — a clinical framework identifying pepsin-mediated posterior nasal mucosal injury as an upstream driver of chronic rhinosinusitis. Preprint available at Preprints.org (DOI: 10.20944/preprints202603.0858.v1). ORCID: 0009-0000-4893-6332.

SinusAndAllergyWellnessCenter.com · 480-525-8999

This content is for educational purposes only and does not constitute medical advice. If you are experiencing persistent morning congestion or nasal obstruction affecting your sleep, consult with a qualified otolaryngologist for a complete evaluation and individualized treatment recommendations.

By Dr. Franklyn R. Gergits, MBA, DO, FAOCO · Board-Certified Otolaryngologist · Fellowship-Trained Otolaryngic Allergist · Clinical Focus in Rhinology and Airway Disorders · 30+ Years of Experience · Founder, Sinus & Allergy Wellness Center of North Scottsdale

The Difference Between GERD and LPR

Most patients know what GERD is — or at least what it feels like. Gastroesophageal reflux disease produces heartburn, that burning sensation behind the sternum that comes after eating acidic foods, lying down after a meal, or consuming alcohol or caffeine. Most people have experienced it at least occasionally. Many have used antacids, H2 blockers, or proton pump inhibitors to manage it. GERD is familiar. Patients recognize it in themselves.

LPR is different — and that is precisely why it gets missed.

In LPR, the refluxate — stomach acid and, critically, the enzyme pepsin — travels not just up the esophagus but all the way past the upper esophageal sphincter into the pharynx, the larynx, and in many cases the posterior nasal cavity. At these anatomical levels, the tissue has little tolerance for acid or pepsin exposure. The mucosal lining of the throat and posterior nasal space was never designed to handle gastric contents. Even brief, intermittent exposure — especially from pepsin, which can remain active in tissue long after the acidic reflux event — causes mucosal inflammation that drives the symptoms patients experience.

But because the reflux does not linger in the esophagus long enough to produce the burning sensation of GERD, patients have no heartburn. They have drainage. They have throat clearing. They have a persistent feeling of something stuck in the throat — what we call globus pharyngeus. They have hoarseness in the morning. They have a cough that never completely resolves. And they have been told, repeatedly, that their sinuses look fine.

Why LPR Is So Difficult to Diagnose — and So Easy to Miss

In an ideal world, diagnosing LPR would involve measuring pepsin levels in the nasal lavage or saliva — a direct biomarker of LPR that would confirm the diagnosis with certainty. The research in this area is advancing. But in current clinical practice, a reliable, accessible office-based pepsin assay is not routinely available. We cannot simply run a test and show a patient: here is your pepsin level, here is the proof that reflux is reaching your throat and nasal lining.

This creates a genuinely difficult clinical conversation. When I tell a patient — who has no heartburn, no GERD history, and no obvious relationship between their symptoms and meals — that I believe silent reflux is driving their chronic drainage, I am asking them to trust a clinical diagnosis without a confirmatory test. And when the treatment I am recommending involves significant dietary and lifestyle changes — eliminating acidic foods, caffeine, alcohol, carbonated beverages, eating nothing for three hours before bed, elevating the head of the bed four to six inches, drinking alkaline water, and potentially starting alginate therapy — I am asking them to make substantial modifications to their daily life on the basis of a clinical judgment rather than a positive test result.

The honest response from many patients is something close to: no thank you. They have lived with the drainage for years. The idea that coffee, wine, and lying down after dinner are the culprits — when they feel no heartburn — is not an easy sell.

I understand that response. And I tell patients I understand it. But I also tell them what happens if the upstream cause is not addressed: the sinus treatments will help temporarily, the drainage will return, the throat clearing will continue, and we will keep treating symptoms that have a cause we have not fixed.

Why the Treatment Feels So Counterintuitive

The LPR treatment protocol — what we sometimes call the no-acid or low-acid approach — targets pepsin as much as it targets acid. This is an important distinction. Pepsin is the enzyme that causes much of the mucosal damage in LPR. Pepsin is activated by acid — so reducing acid exposure reduces pepsin activity. But pepsin can also be reactivated by low-pH substances even after the acute reflux event has passed. This is why alkaline water (pH above 8.8) has a role in LPR management — it can help deactivate pepsin that has already reached the mucosal surface.

The dietary changes that are most impactful: avoiding coffee, alcohol, carbonated beverages, citrus, tomato products, chocolate, and spicy foods. Eating smaller meals. Never eating within three hours of lying down. Sleeping with the head of the bed elevated — not just a pillow, but actual elevation of the bed frame at the head — to use gravity to keep gastric contents below the upper esophageal sphincter overnight.

Alginate preparations — over-the-counter products like Gaviscon Advance — form a physical barrier that floats on top of the gastric contents and prevents reflux from reaching the esophagus and beyond. In LPR, where the problem is the upward migration of the refluxate rather than the volume of acid alone, alginates can be more effective than acid suppressants alone.

None of this is easy. All of it requires commitment. And without a positive test in hand to show the patient, asking for that commitment is one of the more challenging conversations in rhinology.

What Changes When LPR Is Identified and Treated

When a patient commits to the LPR protocol — truly commits, for eight to twelve weeks — and the drainage improves, the throat clearing resolves, and the globus sensation diminishes, the diagnosis becomes self-confirming. The treatment response is the proof. And patients who experience that response invariably understand, in retrospect, what the upstream driver was doing to their airway.

The connection between LPR and chronic rhinosinusitis is one of the central pillars of the Posterior Sinonasal Syndrome framework developed at SAWC — the clinical hypothesis that pepsin-mediated posterior nasal mucosal injury is an upstream driver of chronic rhinosinusitis. When the pepsin reaches the posterior nasal lining, it damages the epithelial barrier, impairs mucociliary clearance, promotes bacterial adhesion, and creates the conditions for recurrent sinus infections. Treating the sinus without addressing the LPR is treating the downstream consequence of an upstream cause that has not been identified.

Dr. G’s Pearls

▸ No heartburn does not mean no reflux. LPR reaches the throat and nose without burning the esophagus. If your drainage, throat clearing, or globus has never responded to sinus treatment — ask your provider specifically about LPR.

▸ Pepsin is the villain in LPR, not just acid. Pepsin can remain active in mucosal tissue and be reactivated by dietary acid even hours after the reflux event. Alkaline water and alginates target pepsin in ways that acid suppressants alone do not.

▸ The three-hour rule before bed is non-negotiable for LPR management. Lying down with a full stomach — even a low-acid stomach — allows refluxate to migrate upward. Gravity is your friend overnight only if you use it correctly.

▸ The LPR treatment protocol is demanding — but so is years of unresolved drainage. Eight weeks of dietary discipline is a reasonable investment to determine whether LPR is the upstream driver of symptoms you have been managing for years without resolution.

▸ If you are being treated for chronic sinus disease and no one has asked about reflux — ask them. LPR is the most consistently missed upstream cause of posterior nasal inflammation in rhinology. It does not announce itself with heartburn. It announces itself with drainage that never responds to antibiotics.

Want to Understand More?

Will Balloon Sinuplasty Correct My Post-Nasal Drainage?

Why Antibiotics Keep Failing Your Sinus Infection

What Is NEUROMARK® and Could It Stop Your Chronic Nasal Symptoms?

Why Can’t I Stop Using Afrin? Understanding Rhinitis Medicamentosa

Why Do I Keep Getting Sinus Infections Even After Surgery?

About the Author

Dr. Franklyn R. Gergits, MBA, DO, FAOCO is a Board-Certified Otolaryngologist and Fellowship-Trained Otolaryngic Allergist with a Clinical Focus in Rhinology and Airway Disorders and over 30 years of clinical experience. He is the founder of the Sinus & Allergy Wellness Center of North Scottsdale, where he performs in-office balloon sinuplasty, turbinate reduction, NEUROMARK® posterior nasal nerve ablation (Neurent Medical, FDA-cleared radiofrequency ablation system), and Eustachian tube dilation under local anesthesia. He performed the first balloon sinuplasty in Pennsylvania and holds dual Entellus Centers of Excellence certifications. Dr. Gergits is the originator of the Posterior Sinonasal Syndrome (PSS) hypothesis — a clinical framework identifying pepsin-mediated posterior nasal mucosal injury as an upstream driver of chronic rhinosinusitis. Preprint available at Preprints.org (DOI: 10.20944/preprints202603.0858.v1). ORCID: 0009-0000-4893-6332.

SinusAndAllergyWellnessCenter.com · 480-525-8999

This content is for educational purposes only and does not constitute medical advice. Laryngopharyngeal reflux requires evaluation and management by a qualified physician. If you believe silent reflux may be contributing to your symptoms, please discuss this with your otolaryngologist or gastroenterologist for individualized evaluation and treatment.

By Dr. Franklyn R. Gergits, MBA, DO, FAOCO · Board-Certified Otolaryngologist · Fellowship-Trained Otolaryngic Allergist · Clinical Focus in Rhinology and Airway Disorders · 30+ Years of Experience · Founder, Sinus & Allergy Wellness Center of North Scottsdale

The Eustachian Tube — The Structure Nobody Talks About Until It Fails

Your Eustachian tube is a small canal that connects the back of your nose — specifically, the nasopharynx — to the middle ear space behind your eardrum. It is approximately 3.5 centimeters long in adults, and it has one primary function: pressure equalization.

Every time you swallow, yawn, or chew, the Eustachian tube briefly opens, allowing a small amount of air to pass between the nasopharynx and the middle ear. This equalizes the pressure on both sides of the eardrum — the atmospheric pressure in the middle ear space is brought into balance with the atmospheric pressure in the room you are in. When this happens normally, you never notice it. When it fails, you notice everything.

The Eustachian tube also has a drainage function. The middle ear space is lined with mucosa — the same type of mucosal tissue that lines your sinuses and nose. That lining produces a small amount of fluid continuously. Under normal conditions, the Eustachian tube drains that fluid passively into the nasopharynx. When the tube is blocked, the fluid accumulates in the middle ear. You feel it as fullness, pressure, or muffled hearing.

How a Blocked Tube Creates Every Ear Symptom You Are Experiencing

When the Eustachian tube becomes narrowed or occluded — from nasal inflammation, anatomical narrowing, mucosal swelling driven by allergy or reflux, or chronic sinus disease pressing against the tube opening — the pressure behind the eardrum can no longer equalize normally. This single mechanical failure produces a cascade of symptoms that can look like a complex ear disorder but is actually a plumbing problem upstream.

Ear fullness and pressure is the most common symptom. The middle ear space is essentially sealed. The pressure differential between the middle ear and the outside world creates the sensation of fullness — the same feeling you get when an airplane descends and you cannot pop your ears. When the Eustachian tube is chronically dysfunctional, that feeling does not resolve with swallowing or yawning. It persists.

Muffled hearing occurs because the eardrum cannot vibrate freely when the pressure behind it is abnormal. The eardrum is designed to respond to the minute pressure variations of sound waves in air. When the middle ear pressure is off — either negative relative to the outside, or when fluid has accumulated — the eardrum becomes stiff and less responsive. Sound reaches the cochlea with less fidelity. Hearing test results may show mild conductive hearing loss, or may appear normal on a standard audiogram while the patient still clearly perceives muffled sound quality.

Tinnitus — ringing, buzzing, or other phantom sounds — can arise when the mechanical tension in the middle ear system is abnormal. The muscles and ligaments attached to the ossicles — the tiny bones of hearing — are under different tension when middle ear pressure is abnormal. This altered mechanical environment can generate phantom sound perception. The tinnitus associated with ETD tends to be low-pitched, fluctuating, and often coincides with pressure changes.

Dizziness occurs because the inner ear — which contains both the cochlea for hearing and the vestibular system for balance — is sensitive to pressure fluctuations. The inner ear is separated from the middle ear space by thin membranes. Abnormal middle ear pressure can transmit mechanical forces across these membranes to the inner ear fluid, disrupting vestibular function. Patients describe this as a sense of imbalance, lightheadedness, or true rotational vertigo in more severe cases.

Ear pain — which can be surprisingly severe — results from the exceptionally dense nerve innervation of the eardrum. The tympanic membrane has one of the highest concentrations of sensory nerve endings of any structure in the body. When pressure differentials stretch or retract the eardrum, those nerve endings fire. The pain can be sharp, throbbing, or constant — and it can be entirely disproportionate to what appears on examination.

Why the Problem Starts in the Nose and Sinuses

This is the connection that most patients have never been told: the mucosal lining of your sinuses is continuous with the mucosal lining of your nose, which extends posteriorly through the nasopharynx directly to the Eustachian tube opening — and from there, that same mucosal continuity extends up into the middle ear space itself.

This is not a metaphor. It is anatomy. The same tissue type that lines your frontal sinus, your maxillary sinus, and your ethmoid cells lines the inside of your Eustachian tube and the middle ear cleft. Inflammation anywhere along this continuous mucosal surface can travel to the Eustachian tube. Nasal polyps can extend into the nasopharynx and physically obstruct the tube opening. Posterior nasal mucosal inflammation — driven by allergy, silent reflux, or posterior sinonasal syndrome — can swell the tissue immediately surrounding the Eustachian tube orifice and narrow or close the tube without any primary ear disease being present at all.

This is why treating the nose aggressively — daily saline rinse, consistent nasal steroid spray twice daily, antihistamine nasal spray when allergy is a driver — so frequently resolves ear symptoms that appeared to have nothing to do with the nose. The nose and the ear are not separate systems. They are one continuous mucosal surface.

When Medical Treatment Is Not Enough — Eustachian Tube Balloon Dilation

When nasal and sinus treatment has been optimized and ear symptoms persist, Eustachian tube balloon dilation is the appropriate next step. This is a ten-minute in-office procedure performed under local anesthesia. A small balloon catheter is advanced through the nasal passage into the Eustachian tube orifice under endoscopic guidance, positioned within the tube, and gently inflated for a brief period. The dilation mechanically opens the tube, improves its function, and allows pressure equalization to resume.

Most patients notice meaningful improvement in ear pressure, fullness, and hearing quality within days to weeks of the procedure. The tinnitus and dizziness associated with ETD frequently improve as pressure normalization is restored. Because the procedure addresses the mechanical root cause — not the symptoms — the improvement tends to be durable.

Dr. G’s Pearls

▸ Any ear symptom — except wax or outer ear infection — may be Eustachian tube dysfunction until proven otherwise. Fullness, pressure, muffled hearing, ringing, dizziness, pain — all of these can originate from a blocked tube, not from primary ear disease.

▸ A normal hearing test does not rule out ETD. Standard audiometry may appear normal while the patient clearly experiences muffled hearing, pressure, or tinnitus. Tympanometry — which measures eardrum mobility and middle ear pressure — is a more sensitive test for ETD and should be part of the evaluation.

▸ The nose and the ear share the same mucosal lining. Treating nasal inflammation aggressively — daily saline rinse plus Flonase twice daily — resolves ear symptoms in a significant proportion of ETD patients because the inflammation driving the tube dysfunction is upstream in the nose.

▸ Ear pain from ETD can be severe and is real. The eardrum is one of the most densely innervated structures in the body. Pressure-related pain from ETD is not anxiety, not TMJ, and not imagined. It is physics — pressure on nerve endings.

▸ If nasal treatment has not resolved your ear symptoms after four to six weeks of consistent use — the tube itself needs to be addressed. Eustachian tube balloon dilation is ten minutes, in the office, under local anesthesia. It changes the outcome for patients who have suffered for months or years without a clear explanation.

Want to Understand More?

What Is NEUROMARK® and Could It Stop Your Chronic Nasal Symptoms?

Why Antibiotics Keep Failing Your Sinus Infection

What Is Balloon Sinuplasty — And Are You a Candidate?

Can Sinusitis Cause Daily Headaches — Or Is It Something Else?

My Doctor Recommended Multiple Procedures — Is That Too Much for One Visit?

About the Author

Dr. Franklyn R. Gergits, MBA, DO, FAOCO is a Board-Certified Otolaryngologist and Fellowship-Trained Otolaryngic Allergist with a Clinical Focus in Rhinology and Airway Disorders and over 30 years of clinical experience. He is the founder of the Sinus & Allergy Wellness Center of North Scottsdale, where he performs in-office balloon sinuplasty, turbinate reduction, NEUROMARK® posterior nasal nerve ablation (Neurent Medical, FDA-cleared radiofrequency ablation system), and Eustachian tube dilation under local anesthesia. He performed the first balloon sinuplasty in Pennsylvania and holds dual Entellus Centers of Excellence certifications. Dr. Gergits is the originator of the Posterior Sinonasal Syndrome (PSS) hypothesis — a clinical framework identifying pepsin-mediated posterior nasal mucosal injury as an upstream driver of chronic rhinosinusitis. Preprint available at Preprints.org (DOI: 10.20944/preprints202603.0858.v1). ORCID: 0009-0000-4893-6332.

SinusAndAllergyWellnessCenter.com · 480-525-8999

This content is for educational purposes only and does not constitute medical advice. If you are experiencing ear pressure, muffled hearing, tinnitus, or dizziness, please consult a qualified otolaryngologist for evaluation. Many ear symptoms have a nasal or sinus origin that responds well to appropriate treatment.

Dr. Franklyn Gergits, ENT · Understanding Your Symptoms · Airway & Sinus Wellness Review

You landed at Sky Harbor, your ears feel like they’re packed with cotton, and the world is slightly tilted. You’re not alone. Ear pressure and dizziness after flying are among the most common complaints I hear from patients — and one of the most misunderstood.

Most people chalk it up to the flight. Pop a yawn, chew some gum, wait it out. But if this keeps happening to you, your ears are telling you something worth listening to.

If you find this helpful, subscribe to the Airway & Sinus Wellness Review for more evidence-based answers to the questions your doctor doesn’t always have time to answer. Free. No spam.

What’s Actually Happening Inside Your Ear

The nasal cavity, sinus mucosa, and the lining of the middle ear are all connected — they share the same continuous mucous membrane system. The Eustachian tube is the narrow channel that runs from the back of your nose up into the middle ear space behind your eardrum. Its job is to equalize pressure on both sides of that eardrum so it can vibrate normally.

At cruising altitude, cabin pressure drops. On descent, it rises again quickly. Your Eustachian tube has to open and close rapidly to keep up — and it does this by briefly opening during swallowing or yawning, equalizing the pressure difference a little at a time.

When the tube doesn’t open properly, pressure builds up behind the eardrum. That pressure differential is what causes the symptoms: ear pain, the feeling of fullness or blockage, muffled hearing, ringing (tinnitus), and — when the pressure change affects the fluid in your inner ear — dizziness. Not just a mild wooziness. For some patients, true spinning vertigo. It’s a miserable feeling and it can last hours to days after landing.

Why Some People Get This Every Flight and Others Never Notice

The people who suffer are usually dealing with Eustachian tube dysfunction — and it comes in two forms.

The first is acute. A cold, a sinus infection, or an allergy flare causes the mucosa around the Eustachian tube opening to swell. The tube can’t open properly, and descent becomes a problem. Flying when you’re congested is the most common trigger. This is why your ears felt fine on the last ten flights and then punished you after you boarded with a runny nose.

The second is chronic. Some patients have Eustachian tube dysfunction that is always present to some degree — structural narrowing, persistent mucosal inflammation from allergies or silent reflux, or underlying nasal obstruction that keeps the tube poorly ventilated. These are the patients who dread flying, avoid it when possible, and never quite feel right in their ears even on the ground. For these patients, flying is not just unpleasant — it can be genuinely disabling.

What to Do Right Now — Before Your Flight Home

If you’re reading this in Phoenix and need to fly home, here is exactly what I tell my patients:

Afrin® Protocol for Flying (Oxymetazoline 0.05%)

• 2 days before your flight:2 sprays to each nostril, twice daily

• Morning of your flight:2 sprays to each nostril

• 30 minutes before boarding:2 sprays to each nostril

• Repeat this same sequence for the flight home

Important: Do not use Afrin for more than 3 consecutive days. It is a short-term flight tool only — not a daily treatment. Extended use causes rebound congestion (rhinitis medicamentosa) that can make things significantly worse.

EarPlanes®

• Drug-free filtered earplugs that slow the rate of pressure change reaching your eardrum

• Available at most drugstores and airport shops

• Safe for ages 1 and up

• Put them in before descent begins — not after your ears start hurting

Also: stay hydrated on the flight. Dehydrated mucosa is thicker and less mobile, which makes Eustachian tube function worse. Drink water, not alcohol, and avoid antihistamines right before flying — they dry the mucosa and can paradoxically worsen tube function despite reducing congestion.

The Longer-Term Answer: Treat the Root Cause

If OTC measures help but don’t solve the problem, or if this happens every single flight regardless of what you do, it’s time to address what’s actually driving it — not just patch around it.

When I see a patient with recurrent flight-related ear problems, we look at the whole picture on the first visit. Is there nasal obstruction limiting airflow to the Eustachian tube opening? Is there active sinus disease contributing to mucosal inflammation? Is there an allergy component or silent reflux keeping the tube edematous? All of these can be identified and treated.

For patients whose Eustachian tube dysfunction is structural — meaning the tube itself is narrowed or poorly functioning independent of inflammation — Eustachian tube balloon dilation is the definitive option. The procedure is done in the office. After you’re comfortable with mild oral sedation and topical numbing, I guide a small balloon catheter through the back of the nose to the Eustachian tube opening. The balloon is gently inflated, held for two minutes, then deflated and removed. We do the other side. You’re in and out in about an hour. No cutting, no packing. Most patients are back to normal activity the next day.

A randomized controlled trial published in Otology & Neurotology showed that balloon dilation improved Eustachian tube symptom scores by -2.9 points versus -0.6 for medical management alone — a statistically and clinically significant difference. For patients who’ve been struggling with this for years, the results can be life-changing.

When to Call Us Before Your Next Flight

If the symptoms from this trip are still present — ear fullness, muffled hearing, pressure, or dizziness that hasn’t fully resolved — don’t wait. Persistent pressure behind the eardrum can cause fluid accumulation in the middle ear space, and that fluid does not always go away on its own. It can lead to hearing loss, ear infections, and in some cases, structural changes to the eardrum.

The message is simple: if this is severe, address the root cause before you fly again. We can evaluate you, identify exactly what’s driving the problem, and give you a plan — whether that’s optimized medical management, balloon dilation, or both. Don’t spend the next trip dreading descent. Call us.

Want to Understand More?

This post is part of the Understanding Your Symptoms series on the Airway & Sinus Wellness Review.

→ Can Sinusitis Cause Daily Headaches? — Airway & Sinus Wellness Review

→ Can Sinus Infections Cause Brain Fog? — Airway & Sinus Wellness Review

→ Will My Obstructive Sleep Apnea Be Cured by Balloon Sinuplasty? — Airway & Sinus Wellness Review

→ Airway & Sinus Wellness Review — Full Publication

Understanding Your Symptoms · Airway & Sinus Wellness Review

About the Author

Dr. Franklyn R. Gergits, MBA, DO, FAOCO is a board-certified otolaryngologist and fellowship-trained otolaryngic allergist with a clinical focus in rhinology and airway disorders, and over 30 years of clinical experience treating sinus and airway disease in Scottsdale and the greater Phoenix metropolitan area. He is the founder of the Sinus & Allergy Wellness Center of North Scottsdale and performed the first balloon sinuplasty in Pennsylvania. He earned Center of Excellence recognition in 2 states and specializes in office-based nasal and sinus procedures under local anesthesia — including balloon sinuplasty, Eustachian tube dilation, and Neuromark posterior nasal nerve ablation. Dr. Gergits is the originator of the Posterior Sinonasal Syndrome (PSS) hypothesis — a clinical framework identifying pepsin-mediated posterior nasal mucosal injury as an upstream driver of chronic rhinosinusitis. Preprint DOI: 10.20944/preprints202603.0858.v1. ORCID: 0009-0000-4893-6332.

SinusAndAllergyWellnessCenter.com · 480-525-8999

This content is for educational purposes only and does not constitute medical advice. If you are experiencing ear pain, persistent dizziness, or hearing loss, please consult a qualified otolaryngologist. For appointments at the Sinus & Allergy Wellness Center of North Scottsdale, call 480-525-8999.

Dr. Franklyn R. Gergits, MBA, DO, FAOCO · Board-Certified Otolaryngologist · Fellowship-Trained Otolaryngic Allergist · 30+ Years of Experience · Clinical Focus in Rhinology and Airway Disorders

Why Afrin Stops Working — and Then Makes Things Worse

When a patient comes into my office admitting they can’t stop using Afrin, the first thing I tell them is this: after about five days of regular use, the medication itself causes the turbinates to swell more. That’s the trap. The patient wants to use more, and more often, to get the same relief — and the turbinates respond by swelling further. That’s the chronicity of rhinitis medicamentosa.

To understand why this happens, you have to understand what the turbinates actually are. The turbinates are vascular structures on the side walls of the nose, lined with erectile tissue — meaning their size changes based on blood flow. When they’re engorged with blood, they’re large. When blood flow decreases, they shrink. Afrin works by causing vasoconstriction — shrinking those vascular structures — which is why it works so quickly and so dramatically the first few times you use it.

But the body adapts. The vessels rebound and swell larger than they were before. Now you have bigger turbinates, more resistance to airflow, and more daytime congestion — driving more spray use.

Why It Gets Worse at Night

Here’s something most patients never have explained to them: when you lie down to sleep, the fluid dynamics in your body change. When you’re upright, gravity pulls blood toward the belly and the legs. When you lie down flat, there’s no gravity pulling blood downward — so the blood distribution becomes more even between the legs, the belly, and the head.

More blood to the head means more blood to the nose. More blood to the nose means more blood to the turbinates. And because those turbinates are vascular erectile structures, they engorge — adding even more congestion and resistance to airflow that’s already compromised by rhinitis medicamentosa.

Now there’s not enough air traveling through the nose to meet the pulmonary demand. The patient opens their mouth to breathe. Once the mouth opens, there can be obstruction further down — which causes vibrations of the soft palate. That’s snoring. Or worse — that’s obstructive sleep apnea.

The Wean-Off Protocol I Use at SAWC

The first thing I ask any patient on Afrin is: have you ever tried stopping cold turkey? If they haven’t tried, I tell them to just stop.

I give them specific instructions. Sleep with your head elevated. Use saline rinses and saline mist as needed throughout the day. Pick a quit date when the first few nights of poor sleep won’t impact work or school — a Friday is often best. And then — this part matters — get rid of every bottle you own.

I mean every bottle. In the medicine cabinet. In the nightstand. In the end table next to your favorite chair. And — this always gets a laugh — the emergency spare bottles hidden in a coat pocket or stuffed inside a shoe in the closet. I had one patient confirm to me that yes, those were the exact locations. Plus the garage. I’d never heard the garage one before.

Why does this matter? Because the first three to four days are rough. Sleep is interrupted and poor quality. Daytime congestion feels worse than ever. If there’s a bottle within reach, the patient will use it. The whole point of the cold-turkey approach is to make relapse impossible.

When Cold Turkey Won’t Work — The Medication-Assisted Wean

If a patient has tried and failed before, I offer them a choice — try again with me coaching, or add medication. Most ask for the medication.

My standard protocol is a tapering oral steroid dose with the highest dose on the first few days. I have patients take the steroid at breakfast — eat half their food, take the pills, then finish breakfast. They start the medication the day before the quit date so it’s already working when Afrin stops.

I also suggest an oral decongestant. If the patient doesn’t have high blood pressure, a history of stroke, heart attack, or cardiac arrhythmia, I’ll recommend the pseudoephedrine that requires showing an ID and signing for it at the pharmacy. It’s far more effective than phenylephrine.

I have them get saline rinse — so when they wake up at 2 a.m. wanting to reach for the Afrin, they can use saline instead.

Sometimes I add a short course of a sleep aid like temazepam to get them through the first week. That’s not for everyone, but for the right patient it can make the difference.

A Patient Story — and a Trick I Now Share With Everyone

One patient told me he was going to save the money he normally spent on Afrin, put it aside, and after two years use it to surprise his wife with something special. I told him that’s a great idea and that I’d be sharing it with other patients. And I do. Afrin isn’t free — and when you add up two or three bottles a month for years, the dollar figure surprises people. Turning that wasted money into a goal gives the wean a positive endpoint, not just the absence of the spray.

Treating the Root Cause — So They Don’t Go Back

The other half of this conversation is just as important. Why did the patient start using Afrin in the first place? If we don’t address the root cause, they’ll be right back on it within a year.

Most of the time, the original problem is nighttime breathing trouble. So I look inside the nose. Is there a deviated nasal septum? If yes, we talk about how the deviation is affecting the nasal airway. Is it allergy that started the congestion at a particular time of year? That points us toward allergy testing. Is it recurrent sinus infections? Then we plan saline rinses followed by a steroid nose spray once they’re off the Afrin.

Here’s where I almost always hear the same response — “but those don’t work.” I tell patients steroid nasal sprays don’t work like Afrin does. They work slowly, on inflammation, not on vascular constriction. I’m recommending them to reduce the risk of infection and to keep the nasal lining calm — not for instant relief.

I also perform an in-office CT scan to see the actual nasal and sinus anatomy. Is there sinusitis present? If so, is it worth treating? Is the patient symptomatic? Sometimes the sinusitis resolves on its own once the Afrin is gone and the chronic inflammation calms down.

When Surgery Becomes the Answer — and the One Rule That Can’t Be Broken

Sometimes surgery is the right answer for the root cause — septoplasty for a significantly deviated septum, turbinate reduction for chronic hypertrophy, balloon sinus dilation if there’s sinus disease driving the inflammation. But surgery cannot happen until the patient is off Afrin.

My ENT attendings taught me to wait a few weeks to a month after the quit day. Many patients fail to stop. I can tell when a patient who says they stopped wasn’t truthful — increased bleeding during the procedure. If that happens and I’m having trouble seeing the landmarks I rely on to orient myself safely, I have to stop the surgery. The risk to the patient is too high to continue.

If a procedure has to be stopped mid-surgery, it gets rescheduled — and only after the patient genuinely confirms they’re off the spray. Unfortunately, other than asking the patient to be honest, there’s no way to know for certain before surgery begins. That’s why the conversation up front is so important.

Once the surgery is completed and full healing has occurred, I stress to the patient the absolute need to promise — to themselves more than to me — never to restart the Afrin. Because if they do, the consequences can be worse than what we just fixed.

The Worst-Case Outcome — Septal Perforation

If a patient restarts Afrin after a septoplasty, there’s a major risk. When I repair a deviated septum, I usually don’t replace the excised septal bone and cartilage. The septum is thinner afterward. If Afrin is then used in both nostrils, the medication hits almost exactly the same spot on both sides of that thinner septum. The vasoconstriction it causes — the very thing that makes Afrin “work” — decreases blood flow to the septum. With decreased blood flow comes tissue necrosis. And with necrosis comes a hole. That’s a septal perforation.

Once a perforation occurs, the entire airflow pattern through the nose changes. With an intact septum — even a deviated one — air moves through the nose in what’s called laminar flow. Air enters through the nostrils, travels front to back smoothly, and the nose does its three core jobs: warm the air, humidify the air, and clean the air before it reaches the lungs.

With a hole in the septum, that flow disappears. Air takes the path of least resistance, which is the hole itself. The flow becomes turbulent. You may hear whistling sounds at night during sleep. The normal function of the nose is eliminated. And when air isn’t being properly conditioned before it hits the lungs, downstream consequences follow — recurrent nosebleeds, sinus infections, even lower airway problems like bronchitis or pneumonia.

Here’s the part that surprises many patients — they don’t always know they have a perforation. I’ve seen multiple patients present with an Afrin addiction and discover during my exam that they already have a septal perforation. And once you have a perforation, it tends to get larger. It can lead to chronic rhinosinusitis. If treatment requires multiple courses of antibiotics, resistant infections and biofilms can develop — affecting both the bacteria in the gut and the healthy lining of the nose, sinuses, and airway. Some patients end up hospitalized or on home IV antibiotics through a PICC line. That’s a scary place to find yourself for what started as a stuffy nose.

The Patient Who’s Been on Afrin for Years — or Decades

If a patient has been using Afrin for years, I still try my hardest to get them off the medication. The approach is the same — but the coaching has to be more patient.

I had a family of three all hooked on Afrin. Dad, Mom, and a teenage daughter. Dad had started first, many years ago. Mom started after a bad allergy season — and since she thought it worked for her, she suggested it to her daughter when the daughter developed trouble sleeping. All three came in to see me at the same time.

Dad stopped first, cold turkey. No problem — with the coaching, he understood it would take time to feel the way he did before Afrin, and he was patient with the process.

Mom stopped second. She needed the medication-assisted protocol — the steroid taper plus Benadryl at nighttime to help her sleep.

The daughter had the roughest time. With her, we went slower. I added azelastine — a prescription topical antihistamine nasal spray. Instead of two sprays of Afrin two to three times a day, she halved her Afrin use and added azelastine. Over time, she transitioned fully to just using azelastine, which was actually treating the underlying year-round allergy that had driven her to Afrin in the first place.

That family taught me something important. Long-term users can get off the spray. But the protocol may need to be individualized, the timeline extended, and the root cause addressed for each person separately.

What About Other Nasal Sprays — Are Any of Them Safe?

It’s not just Afrin that causes this problem. Any over-the-counter decongestant nasal spray with oxymetazoline (Afrin, Vicks Sinex) or phenylephrine (Neo-Synephrine, some Sinex products) can cause rebound congestion and rhinitis medicamentosa. The mechanism is the same — vasoconstriction followed by rebound vasodilation.

Some patients tell me they won’t even try an over-the-counter steroid nasal spray because they’re afraid it will cause an Afrin-like addiction. I work hard to reassure them. Most believe me. Some don’t — because they’ve watched a family member, a friend, or a colleague suffer through Afrin dependence and they refuse to risk putting anything in their nose. I get that. I respect that.

The nasal sprays that are safe for long-term use without rebound risk are:

• Steroid nasal sprays — Flonase, Nasacort, Nasonex

• Topical antihistamine sprays — azelastine, olopatadine

• Anticholinergic sprays — ipratropium

• Combination sprays — Dymista, Ryaltris

• Mast cell stabilizers — Nasalcrom

• Saline rinses or saline mist

I try to inform patients of the safety profile of these alternatives and give them direction on using these sprays mechanically — meaning, correctly aimed and at the right dose. When patients can’t tolerate any spray due to past Afrin experience, we treat the root cause through other means. That’s usually the better path anyway.

Want to Understand More?

→ Why Antibiotics Keep Failing Your Sinus Infections

→ Why Do I Keep Getting Sinus Infections Even After Surgery?

→ What Is Balloon Sinuplasty and Are You a Candidate?

About the Author

Franklyn R. Gergits, DO, MBA, FAOCO is an otolaryngologist and rhinologist with over 30 years of clinical experience. He is the founder of the Sinus & Allergy Wellness Center of North Scottsdale, where he performs in-office balloon sinuplasty, turbinate reduction, NEUROMARK® posterior nasal nerve ablation (Neurent Medical, FDA-cleared radiofrequency ablation system), and Eustachian tube dilation under local anesthesia. He performed the first balloon sinuplasty in Pennsylvania and holds dual Entellus Centers of Excellence certifications. Dr. Gergits is the originator of the Posterior Sinonasal Syndrome (PSS) hypothesis, with a preprint available at Preprints.org (DOI: 10.20944/preprints202603.0858.v1). ORCID: 0009-0000-4893-6332.

SinusAndAllergyWellnessCenter.com · 480-525-8999

This content is for educational purposes only and does not constitute medical advice. If you are dependent on Afrin or another over-the-counter decongestant nasal spray, please consult a qualified physician.

Dr. Franklyn R. Gergits, MBA, DO, FAOCO · Board-Certified Otolaryngologist · Fellowship-Trained Otolaryngic Allergist · 30+ Years of Experience · Clinical Focus in Rhinology and Airway Disorders

Patients are noticing something new at the pharmacy. Migraine medications, hormone therapies, anti-nausea drugs, even rescue medications — they are showing up as nasal sprays instead of pills. And the questions follow immediately.

Why is my doctor prescribing this through my nose? Won’t it irritate my sinuses? Will my rinse wash it away? Will it even reach the medication target if my nose is stuffy or blocked? Could it cause infections or headaches?

These are good questions. Patients are right to ask them. As an otolaryngologist and otolaryngic allergist with over 30 years of clinical experience focused on the nose and sinuses, I want to walk through exactly what is happening, why the nose is being used, and what the real concerns are versus what is not a concern at all.

Why are medications being delivered through the nose in the first place?

The nose is not just an airway. It is one of the most vascular surfaces in the entire body. The lining is thin, the blood supply is rich, and the surface area is enormous once you account for the turbinates and the sinus openings.

When a medication is swallowed as a pill, it has to survive the stomach acid, get absorbed through the gut, and pass through the liver before any of it reaches the bloodstream. The liver breaks down a significant percentage of the drug before it ever gets where it needs to go. This is called first-pass metabolism, and it is the reason oral doses are often much higher than the body actually needs.

A nasal spray skips all of that. The medication is absorbed directly into the bloodstream through the nasal lining. It reaches therapeutic levels faster, often at a lower dose, with less load on the liver and less risk of gastrointestinal side effects. For migraine, anti-nausea, and rescue medications in particular, speed of onset matters — and the nasal route delivers it.

Won’t the spray cause nasal or sinus irritation?

This is the most common concern I hear, and it is a fair one. Anything you put on the nasal lining repeatedly has the potential to irritate it.

The truth is: most properly formulated nasal medications do not cause significant mucosal irritation when used as directed. The pharmaceutical companies developing these formulations spend years adjusting pH, osmolarity, and preservative content specifically to be tolerated by the nasal lining. Burning, stinging, or dryness in the first few uses is usually transient and improves as the lining adapts.

The bigger irritation risk is not the active medication — it is the preservative or the propellant. Some patients are sensitive to benzalkonium chloride, which is the most common preservative in nasal sprays. If you notice persistent burning or worsening congestion after starting a new nasal spray, tell your doctor. There are preservative-free formulations and alternative delivery systems available.

Will my sinus rinse wash the medication away?

Yes — and that is why timing matters.

If you use a saline rinse and then immediately spray your medication, you have a clean, moist surface for the drug to absorb into. That is ideal.

If you use your medication and then rinse afterward, you have just washed the medication out before it had time to absorb. That is a wasted dose.

The rule I give my patients is simple: rinse first, then medicate. Give the rinse 10 to 15 minutes to let the lining settle, then administer your nasal medication. Do not rinse again for at least an hour, ideally longer.

Will it work if my nose is stuffy or congested?

This is the question that matters most clinically, and the honest answer is: it depends on what is causing the congestion.

If your nose is congested from mucus, blow gently or rinse first. The medication needs to reach the lining, not sit on a mucus layer.

If your nose is congested from swollen turbinates due to allergies or inflammation, you may need to address that first. A short course of a decongestant nasal spray (used for no more than 3 days to avoid rebound) or an antihistamine can open the nose enough to let the therapeutic medication reach the lining. Better yet, treat the underlying inflammation with a nasal steroid spray on a regular schedule so the airway stays open and absorption stays consistent.

If your nose is congested from structural issues — a deviated septum, enlarged turbinates, or polyps — then a nasal spray may not absorb evenly. The medication will reach the open side of the nose but may not get good contact on the blocked side. This is a real limitation, and it is one of the reasons I evaluate the structural airway before assuming a nasal medication is failing.

What if I have a deviated septum?

A deviated septum changes the airflow pattern through the nose. The medication still gets in, but it is delivered unevenly — one side absorbs well, the other side does not.

For most patients with a mild deviation, this is not a major issue because the systemic dose reaching the bloodstream is still sufficient. For patients with severe deviations or significant turbinate hypertrophy, absorption can be inconsistent enough that the medication appears to fail when it is really a delivery problem.

If your nasal spray seems to work some days and not others, and you know you have a deviated septum, that is worth discussing. The structural problem is fixable.

Will the spray cause my nose to block up even more?

Used correctly, no. Used incorrectly, yes — and this is where patients get into trouble.

The class of nasal sprays that causes rebound congestion is the decongestant class — oxymetazoline (Afrin) and phenylephrine. These shrink the swollen blood vessels in the turbinates and open the nose immediately. But after 3 to 5 days of continuous use, the lining becomes dependent on the spray, and stopping it causes severe rebound swelling. This is called rhinitis medicamentosa, and it is a real problem I see in clinic every week.

Other nasal sprays — steroid sprays, antihistamine sprays, and most prescription delivery systems — do not cause this. They are safe for long-term daily use. The blocking effect comes specifically from overusing the decongestant class.

Can the spray cause infections, headaches, or sinusitis?

The spray itself does not cause infection. The bottle, however, can be a contamination source if it is shared, if the tip touches the nasal lining repeatedly without cleaning, or if it is used past its expiration date.

A clean technique is straightforward: wipe the tip with alcohol periodically, never share the bottle, do not insert the tip deeply into the nose, and replace the bottle when the expiration date passes.

Headaches from nasal sprays are uncommon. When they do occur, they are usually from the preservative, from over-vigorous spraying that drives medication into the sinus openings under pressure, or from the underlying condition the spray is treating — not from the spray itself.

Sinusitis is not caused by nasal sprays. Sinusitis is caused by ostial obstruction, inflammation, and bacterial colonization. A properly used nasal spray that controls inflammation actually reduces the risk of sinusitis by keeping the sinus openings clear.

How does the medication actually work if I am not swallowing it?

The nasal lining is a delivery system. Underneath the surface mucosa is a dense network of blood vessels — the same vessels that warm and humidify the air you breathe. When a medication is sprayed onto this surface, it dissolves into the mucus layer, contacts the underlying tissue, and is absorbed directly into those blood vessels.

From there it enters the systemic circulation and reaches the rest of the body the same way an oral medication eventually would — but faster, at a lower dose, and without the liver filtering most of it out first.

For medications that target the brain — migraine drugs, certain hormones, rescue medications for seizures or overdoses — the nasal route has another advantage. The upper portion of the nasal cavity has direct connections to the brain through the olfactory nerve pathway and surrounding structures. This is being actively studied as a way to deliver drugs across the blood-brain barrier without injection.

Dr. G’s Pearls

• Rinse first, then medicate — never the other way around. Give the rinse 10 to 15 minutes before the medication, and do not rinse again for at least an hour after.

• Burning or stinging in the first few uses is usually the preservative, not the active drug. Tell your doctor — preservative-free versions exist.

• If a nasal spray works on some days and not others, look at your airway. A deviated septum or swollen turbinates may be the reason the medication is delivered unevenly.

• Decongestant sprays (Afrin, phenylephrine) are the only class that causes rebound congestion. Steroid and antihistamine sprays are safe for daily long-term use.

• The nose is one of the fastest absorption surfaces in the body. That is a feature, not a side effect — it is the reason your doctor chose the nasal route.

Want to Understand More?

→ Will Balloon Sinuplasty Correct My Post-Nasal Drip?

→ Why Antibiotics Keep Failing Your Sinus Infections

→ What Is Balloon Sinuplasty and Are You a Candidate?

About the Author

Franklyn R. Gergits, DO, MBA, FAOCO is an otolaryngologist and rhinologist with over 30 years of clinical experience. He is the founder of the Sinus & Allergy Wellness Center of North Scottsdale, where he performs in-office balloon sinuplasty, turbinate reduction, NEUROMARK® posterior nasal nerve ablation (Neurent Medical, FDA-cleared radiofrequency ablation system), and Eustachian tube dilation under local anesthesia. He performed the first balloon sinuplasty in Pennsylvania and holds dual Entellus Centers of Excellence certifications. Dr. Gergits is the originator of the Posterior Sinonasal Syndrome (PSS) hypothesis, with a preprint available at Preprints.org (DOI: 10.20944/preprints202603.0858.v1). ORCID: 0009-0000-4893-6332.

SinusAndAllergyWellnessCenter.com · 480-525-8999

This content is for educational purposes only and does not constitute medical advice. If you are experiencing chronic congestion, please consult a qualified physician for evaluation and individualized treatment recommendations.

By Dr. Franklyn Gergits, ENT · Sinus & Allergy Wellness Center of North Scottsdale · SinusAndAllergyWellnessCenter.com

One of the most common questions patients ask after deciding they want NEUROMARK® is whether their insurance will pay for it. It is a fair and important question, and the honest answer is: it depends on your specific plan — but the landscape is improving, and our team works hard to get every patient covered.

Thanks for reading Airway & Sinus Wellness Review. Subscribe free to receive new posts and support this work.

Why Coverage Is Still Catching Up

NEUROMARK® is a newer addition to the in-office procedural toolkit for chronic rhinitis. Insurance coverage for newer procedures typically lags behind clinical adoption — insurers require a body of published evidence, utilization data, and sometimes a formal policy review process before adding a procedure to their covered benefit list. That process takes time, even when the clinical evidence is strong and the procedure is FDA-cleared.

This does not mean the procedure is experimental or unproven. It means the administrative machinery of insurance coverage moves more slowly than clinical innovation. As more ENT physicians across the country perform NEUROMARK® and submit claims — and as more patients advocate for themselves — that machinery begins to move.

What Our Authorization Team Does for You

At SAWC, we do not ask patients to figure out their coverage on their own. Our insurance authorization team verifies your specific benefits before any procedure is scheduled. If your plan covers NEUROMARK® under CPT code 31242, we handle the prior authorization process directly.

If your plan does not yet cover the procedure, our team submits a formal appeal on your behalf. Appeals include clinical documentation of your symptoms, the treatment you have already tried, your diagnostic findings, and the published clinical evidence supporting NEUROMARK® as an effective and appropriate treatment. As more appeals accumulate with any given insurer — demonstrating that ENT physicians across the country are consistently advocating for their patients — the insurer’s position on coverage becomes increasingly difficult to maintain.

Insurers Currently Less Likely to Cover

Based on our current experience at SAWC, Blue Cross Blue Shield, Anthem, and Aetna have been among the plans less likely to provide coverage without an appeal. That said, coverage decisions vary by specific plan, geographic region, and policy year — and these positions change as more data accumulates and more appeals are filed. A plan that denied coverage last year may have updated its policy this year. Our authorization team checks current coverage status for your specific plan at the time of your evaluation.

The CPT Code — 31242

The procedure is billed under CPT code 31242 — nasal/sinus endoscopy, surgical, with posterior nasal neurectomy, including sphenopalatine ganglion. This is the correct code for endoscopic posterior nasal nerve treatment, and it is the code submitted for authorization. When speaking with your insurance company directly, referencing this code gives their representatives the specific information they need to look up your plan’s coverage policy.

How You Can Help Your Own Coverage

Patients who call their insurance company directly and advocate for themselves have made a real difference in how insurers view this procedure. When a member calls and explains — in their own words — the impact their chronic drainage, cough, ear symptoms, or sleep disruption has on their daily life, and asks specifically why a safe, FDA-cleared, in-office procedure is being denied, the insurer hears something different than a form letter from a physician’s office. They hear from the person whose health is actually affected.

It becomes increasingly difficult for an insurance company to argue that a procedure is investigational when multiple major insurers are covering it, when the published clinical evidence is accumulating, and when their own members are calling to say their quality of life depends on it. You have every right to appeal a denial, to ask for a peer-to-peer review between your physician and the insurer’s medical director, and to escalate if needed. Our team supports you through that process.

When Coverage Is Not Available

For patients whose insurance does not cover NEUROMARK® and whose appeals are unsuccessful, the out-of-pocket cost is determined by SAWC’s disposable handpiece cost and facility fees. Our authorization team provides the specific cost figure at the time of your evaluation — the number is driven by the actual cost of the single-use device components, not by an arbitrary price point. We encourage patients to ask directly so there are no surprises.

Want to Understand More?

This post is part of the Understanding Your Symptoms series on the Airway & Sinus Wellness Review.

→ What Is NEUROMARK® — and Could It Stop Your Chronic Runny Nose?

→ Does Balloon Sinuplasty Actually Work?

→ Is the Combination Procedure Too Much?

→ What Is Balloon Sinuplasty — and Are You a Candidate?

→ Airway & Sinus Wellness Review — Full Publication

Understanding Your Symptoms — Clinical education from the Sinus & Allergy Wellness Center of North Scottsdale.

About the Author

Dr. Franklyn R. Gergits, DO, MBA, FAOCO is a board-certified otolaryngologist and otolaryngic allergist with a focus in rhinology with over 30 years of clinical experience treating sinus and airway disease in Scottsdale and the greater Phoenix metropolitan area. He is the founder of the Sinus & Allergy Wellness Center of North Scottsdale and performed the first balloon sinuplasty in Pennsylvania. He holds dual Entellus Centers of Excellence certifications and specializes in comprehensive, personalized, office-based nasal and sinus care — including balloon sinuplasty, NEUROMARK® posterior nasal nerve treatment, Eustachian tube dilation, nasal airway surgery, and comprehensive allergy testing and immunotherapy. Dr. Gergits is the originator of the Posterior Sinonasal Syndrome (PSS) hypothesis — a clinical framework identifying pepsin-mediated posterior nasal mucosal injury as an upstream driver of chronic rhinosinusitis. ORCID: 0009-0000-4893-6332. Preprint DOI: 10.20944/preprints202603.0858.v1. Dr. Gergits has no financial relationship with Neurent Medical.

SinusAndAllergyWellnessCenter.com · 480-525-8999

This content is for educational purposes only and does not constitute medical advice. Please consult a qualified physician for evaluation and treatment of your specific condition. NEUROMARK® is a registered trademark of Neurent Medical. CPT code information is provided for general reference only — coverage decisions are plan-specific and subject to change.

By Dr. Franklyn Gergits, ENT · Sinus & Allergy Wellness Center of North Scottsdale · SinusAndAllergyWellnessCenter.com

When patients consider NEUROMARK®, one of the first questions they ask is about risk. That is exactly the right question to ask, and it deserves a complete and honest answer — not a brochure summary. What follows is the same conversation I have with every patient before we proceed.

Thanks for reading Airway & Sinus Wellness Review. Subscribe free to receive new posts and support this work.

The Most Common Experience — Mild Discomfort in Specific Patients

The most frequently reported post-procedure experience at SAWC is mild discomfort — and even this is not universal. The patients who are most likely to notice it are those who have had extensive prior endoscopic sinus surgery, where the surgical resection of normal anatomical landmarks makes delivering local anesthesia to the precise posterior nasal locations more technically challenging.

When normal anatomy has been altered by prior FESS, the usual reference points I rely on to place anesthetic precisely are changed or absent. Early in our NEUROMARK® experience, this created cases where anesthesia was less complete than ideal. We have since developed improved anesthesia protocols specifically for the post-surgical nose — additional steps, modified injection points, and a longer anesthesia dwell time — that have substantially addressed this challenge. Patients with a history of prior sinus surgery should let us know at their evaluation so we can plan accordingly.

Throat Numbness — Temporary and Manageable

Some patients notice throat numbness following the procedure. This occurs when the topical anesthetic gel used during the preparation phase migrates posteriorly into the nasopharynx and oropharynx. It is temporary, typically resolving within 30 to 60 minutes as the medication wears off.

While the throat is numb, there are two practical things to be aware of. First, avoid hot beverages. The numbness removes your ability to sense temperature accurately — so that hot coffee from Starbucks on your way home could burn your throat before you realize it. If you have your heart set on coffee after the procedure, ask for it at room temperature, or in Arizona, an iced coffee is a perfectly reasonable solution. Second, when you do drink anything, start with baby sips. The numbness temporarily affects not just sensation but also the coordination of swallowing — the muscular sequence that moves a liquid safely from your mouth to your stomach. Small sips give your swallow reflex time to work without being overwhelmed. Once the medication has fully worn off, there are no restrictions on food, beverages, or temperature.

Empty Nose Syndrome — Why It Is Not a Risk Here

Empty nose syndrome is one of the most feared complications of nasal surgery, and for good reason — it is a devastating condition in which patients paradoxically feel unable to breathe despite a wide open nasal airway, caused by the surgical removal of too much turbinate tissue. Patients ask about it often, and the concern is completely understandable.

NEUROMARK® does not carry this risk. Empty nose syndrome occurs because mucosal surface area is physically eliminated — the sensory receptors that register airflow, temperature, and humidity are removed along with the tissue. NEUROMARK® does none of this. The radiofrequency energy down-regulates nerve activity. It does not excise, destroy, or lyse the nerves. It does not remove any mucosal surface. The tissue remains. The receptors remain. The architecture of the nasal cavity is entirely unchanged. The nerve activity is simply modulated to a lower, healthier baseline.

In my clinical experience at SAWC, not a single patient has reported a nose that became excessively dry or that lost the normal sense of airflow following NEUROMARK®. Drainage is reduced — that is the goal — but it is not eliminated. The nose continues to function normally. It simply stops overproducing.

What the Published Literature Shows

Across the published clinical trials and multicenter studies on radiofrequency posterior nasal nerve treatment, serious adverse events have not been reported. Minor adverse events — including temporary discomfort, mild swelling, and transient changes in sensation — occurred in approximately 7.4% of patients across the published literature and resolved without intervention. No permanent loss of nasal function, no structural damage, and no cases of empty nose syndrome have been reported in the published evidence base for this device class.

NEUROMARK® is an FDA-cleared device. The radiofrequency energy delivery is pre-set and calibrated — it is not adjustable in the moment, which means there is no risk of inadvertent over-treatment from operator error in the energy delivery itself.

Having an Honest Conversation at Your Evaluation

The best way to understand your personal risk profile is to have a complete conversation at your evaluation. Patients with prior sinus surgery, significant anatomical variations, or complex medical histories may have a different pre-procedure preparation than straightforward cases — and that is something we plan for specifically, not something we discover during the procedure. At SAWC, the evaluation is where we make those determinations, and where you get answers to every question you bring with you.

Want to Understand More?

This post is part of the Understanding Your Symptoms series on the Airway & Sinus Wellness Review.

→ What Is NEUROMARK® — and Could It Stop Your Chronic Runny Nose?

→ Is Balloon Sinuplasty Painful?

→ Will Balloon Sinuplasty Correct My Post-Nasal Drainage?

→ Is the Combination Procedure Too Much?

→ Airway & Sinus Wellness Review — Full Publication

Understanding Your Symptoms — Clinical education from the Sinus & Allergy Wellness Center of North Scottsdale.

About the Author

Dr. Franklyn R. Gergits, DO, MBA, FAOCO is an osteopathic otolaryngologist and otolaryngic allergist with a focus in rhinology with over 30 years of clinical experience treating sinus and airway disease in Scottsdale and the greater Phoenix metropolitan area. He is the founder of the Sinus & Allergy Wellness Center of North Scottsdale and performed the first balloon sinuplasty in Pennsylvania. He holds dual Entellus Centers of Excellence certifications and specializes in comprehensive, personalized, office-based nasal and sinus care — including balloon sinuplasty, NEUROMARK® posterior nasal nerve treatment, Eustachian tube dilation, nasal airway surgery, and comprehensive allergy testing and immunotherapy. Dr. Gergits is the originator of the Posterior Sinonasal Syndrome (PSS) hypothesis — a clinical framework identifying pepsin-mediated posterior nasal mucosal injury as an upstream driver of chronic rhinosinusitis. ORCID: 0009-0000-4893-6332. Preprint DOI: 10.20944/preprints202603.0858.v1. Dr. Gergits has no financial relationship with Neurent Medical.

SinusAndAllergyWellnessCenter.com · 480-525-8999

This content is for educational purposes only and does not constitute medical advice. Please consult a qualified physician for evaluation and treatment of your specific condition. NEUROMARK® is a registered trademark of Neurent Medical.

By Dr. Franklyn Gergits, ENT · Sinus & Allergy Wellness Center of North Scottsdale · SinusAndAllergyWellnessCenter.com

If you have researched posterior nasal nerve treatment online, you have encountered three device names: NEUROMARK®, ClariFix®, and RhinAer®. All three are FDA-cleared. All three target the posterior nasal nerve. All three are marketed for chronic rhinitis with excessive post-nasal drainage, runny nose, and congestion. And all three produce results that patients report as meaningful.

So why does the choice of device matter — and why does SAWC use NEUROMARK® exclusively?

Thanks for reading Airway & Sinus Wellness Review. Subscribe free to receive new posts and support this work.

The Three Devices — A Brief Overview

ClariFix® was the first to market, FDA-cleared in 2017. It uses cryotherapy — liquid nitrogen delivered via an inflatable balloon placed endoscopically into the sphenopalatine ganglion region. The balloon is inflated, freezing the nerve tissue, and then removed. The mechanism is ablation through extreme cold rather than heat.

RhinAer® uses temperature-controlled radiofrequency energy delivered through a point-contact stylus tip. It targets the posterior nasal nerve at the sphenopalatine foramen and the posterior lateral nasal wall. RhinAer is manufactured by Aerin Medical, which was acquired by Stryker — the same company that makes ClariFix. Both devices are now in the Stryker portfolio.

NEUROMARK® uses temperature-controlled radiofrequency energy delivered through curved wire paddles rather than a point-contact tip. It is manufactured by Neurent Medical, an independent company. SAWC has no financial relationship with Neurent Medical.

Energy Modality — Radiofrequency vs Cryotherapy

The most fundamental difference is between radiofrequency energy and cryotherapy — the technologies used by NEUROMARK® and RhinAer® on one side, and ClariFix® on the other.

A published meta-analysis comparing the two modalities found that radiofrequency neurolysis was significantly more effective than cryotherapy in reducing total nasal symptom scores, with particularly superior results for rhinorrhea, congestion, and itching at up to 12 months of follow-up. A separate multicenter cohort study found that after ClariFix® cryoablation, 95% of patients experienced some degree of rhinorrhea recurrence by a mean of five months post-procedure, with 65% returning completely to their preoperative symptom levels. By contrast, the three-year published data for temperature-controlled radiofrequency shows sustained 57.7% improvement in total nasal symptom scores, with 80% of patients maintaining clinically meaningful benefit at two years.

There is also a safety consideration specific to ClariFix®. Patients who receive cryotherapy with insufficient pre-procedural anesthesia can experience severe, intense cephalgia — an acute and painful headache triggered by the cold delivery. This risk profile is not present with radiofrequency devices. At SAWC, our pre-procedural anesthesia protocol is extensive and deliberate precisely because patient comfort is a clinical priority — but the radiofrequency modality we use does not carry the cryotherapy-specific risk regardless.

Surface Area and Anatomical Reach — Where the Devices Differ Most

The second meaningful difference is in the surface area treated per energy delivery and the anatomical territory each device can reach.

RhinAer® uses a point-contact stylus. Accurate placement at the precise nerve location is required for effective treatment — the contact area is small, and precise positioning matters. NEUROMARK®’s curved wire paddle design covers significantly more mucosal territory per treatment position. The larger surface area means that less positional precision is required and coverage is more complete — the energy reaches the nerve network across a broader region rather than requiring a bullseye placement.

More importantly, NEUROMARK®’s paddle design allows treatment to extend inferior along the posterior lateral nasal wall and into the posterior nasopharynx — territory that ClariFix® and RhinAer® cannot anatomically access. This posterior nasopharyngeal reach is what enables treatment of the peripheral branches of the posterior nasal nerve and the adjacent trigeminal nerve bundle in that region. It is why NEUROMARK® patients with Eustachian tube dysfunction report ear symptom improvement that ClariFix® and RhinAer® patients do not consistently experience — the device is reaching the nerve branches that serve the Eustachian tube orifice.

"The differences summarized above translate directly into the clinical decision SAWC made when selecting a device for our procedure suite."

Putting It Together — The Differences That Matter

All three devices are FDA-cleared and all three produce results that patients report as meaningful. But when you look at the evidence closely, the differences are not subtle.

On energy modality, NEUROMARK® and RhinAer® both use radiofrequency energy. ClariFix® uses cryotherapy — liquid nitrogen delivered through an inflatable balloon. The published meta-analysis comparing these two approaches found radiofrequency significantly more effective at reducing total nasal symptom scores, with particular advantages in rhinorrhea, congestion, and itching at up to 12 months. A multicenter cohort study found that 95% of ClariFix® patients experienced some degree of symptom recurrence by a mean of five months, with 65% returning completely to their preoperative baseline. The three-year radiofrequency data shows 57.7% sustained improvement with 80% of patients maintaining meaningful benefit at two years. That is not a small difference for a patient deciding between procedures.

On delivery design, RhinAer® uses a point-contact stylus that requires precise placement at the nerve location. NEUROMARK®’s curved wire paddles cover significantly more mucosal surface area per treatment position — less precision required, more territory covered. More importantly, the paddle design extends inferior into the posterior nasopharynx, reaching nerve branches that neither RhinAer® nor ClariFix® can anatomically access. That extended reach is what produces the Eustachian tube benefit we observe clinically at SAWC — and it is a reach the other two devices simply do not have.

On safety, both radiofrequency devices are free of the cephalgia risk that ClariFix® carries when pre-procedural anesthesia is insufficient. That is not a theoretical risk — it is documented and it is one of the reasons we do not use cryotherapy at SAWC.

Why SAWC Uses NEUROMARK® Exclusively

The decision to use NEUROMARK® exclusively at SAWC reflects a clinical judgment about which device best serves the patient population we treat. Our patients frequently present with a combination of posterior drainage, Eustachian tube dysfunction, and symptoms that point to posterior nasal nerve overactivation as part of a broader posterior sinonasal inflammatory pattern. The extended anatomical reach of NEUROMARK®, combined with its radiofrequency modality and the superior three-year durability data for that modality class, makes it the best available tool for that clinical picture.

We also considered the published recurrence data for cryotherapy carefully. A procedure that produces meaningful initial results but returns 65% of patients to their preoperative baseline within five months is not a long-term solution for a chronic condition. Our patients deserve durable results — and the radiofrequency data supports that expectation.

SAWC has no financial relationship with Neurent Medical. We use NEUROMARK® because the clinical evidence supports it as the superior choice for our patient population.

Want to Understand More?

This post is part of the Understanding Your Symptoms series on the Airway & Sinus Wellness Review.

→ What Is NEUROMARK® — and Could It Stop Your Chronic Runny Nose?

→ Does Balloon Sinuplasty Actually Work?

→ Will Balloon Sinuplasty Correct My Post-Nasal Drainage?

→ Is the Combination Procedure Too Much?

→ Airway & Sinus Wellness Review — Full Publication

Understanding Your Symptoms — Clinical education from the Sinus & Allergy Wellness Center of North Scottsdale.

About the Author

Dr. Franklyn R. Gergits, DO, MBA, FAOCO is an osteopathic otolaryngologist and otolaryngic allergist with a focus in rhinology with over 30 years of clinical experience treating sinus and airway disease in Scottsdale and the greater Phoenix metropolitan area. He is the founder of the Sinus & Allergy Wellness Center of North Scottsdale and performed the first balloon sinuplasty in Pennsylvania. He holds dual Entellus Centers of Excellence certifications and specializes in comprehensive, personalized, office-based nasal and sinus care — including balloon sinuplasty, NEUROMARK® posterior nasal nerve treatment, Eustachian tube dilation, nasal airway surgery, and comprehensive allergy testing and immunotherapy. Dr. Gergits is the originator of the Posterior Sinonasal Syndrome (PSS) hypothesis — a clinical framework identifying pepsin-mediated posterior nasal mucosal injury as an upstream driver of chronic rhinosinusitis. ORCID: 0009-0000-4893-6332. Preprint DOI: 10.20944/preprints202603.0858.v1. Dr. Gergits has no financial relationship with Neurent Medical.

SinusAndAllergyWellnessCenter.com · 480-525-8999

This content is for educational purposes only and does not constitute medical advice. Please consult a qualified physician for evaluation and treatment of your specific condition. NEUROMARK® is a registered trademark of Neurent Medical. ClariFix® is a registered trademark of Stryker. RhinAer® is a registered trademark of Aerin Medical, Inc. Dr. Gergits has no financial relationship with any device manufacturer mentioned in this article.